KR100975278B1 - Extraction method of opuntia humifusa using enzyme hydrolysis - Google Patents
Extraction method of opuntia humifusa using enzyme hydrolysis Download PDFInfo
- Publication number
- KR100975278B1 KR100975278B1 KR1020100007416A KR20100007416A KR100975278B1 KR 100975278 B1 KR100975278 B1 KR 100975278B1 KR 1020100007416 A KR1020100007416 A KR 1020100007416A KR 20100007416 A KR20100007416 A KR 20100007416A KR 100975278 B1 KR100975278 B1 KR 100975278B1
- Authority
- KR
- South Korea
- Prior art keywords
- cheonnyeoncho
- extract
- millennial
- rapidase
- humifusa
- Prior art date
Links
- 108090000790 Enzymes Proteins 0.000 title claims description 74
- 102000004190 Enzymes Human genes 0.000 title claims description 74
- 230000007062 hydrolysis Effects 0.000 title claims description 55
- 238000006460 hydrolysis reaction Methods 0.000 title claims description 55
- 238000000605 extraction Methods 0.000 title description 7
- 235000000039 Opuntia compressa Nutrition 0.000 title description 4
- 241000454613 Opuntia humifusa Species 0.000 title description 4
- 239000000284 extract Substances 0.000 claims abstract description 95
- 239000000203 mixture Substances 0.000 claims abstract description 70
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 63
- 235000013305 food Nutrition 0.000 claims abstract description 42
- 238000000034 method Methods 0.000 claims abstract description 38
- 238000004519 manufacturing process Methods 0.000 claims abstract description 22
- 239000002537 cosmetic Substances 0.000 claims abstract description 20
- 238000001914 filtration Methods 0.000 claims abstract description 15
- 238000005406 washing Methods 0.000 claims abstract description 10
- 230000000694 effects Effects 0.000 claims description 32
- 230000003078 antioxidant effect Effects 0.000 claims description 23
- 230000008569 process Effects 0.000 claims description 17
- 239000003963 antioxidant agent Substances 0.000 claims description 14
- 230000003301 hydrolyzing effect Effects 0.000 claims description 12
- 230000001869 rapid Effects 0.000 claims description 11
- 235000015872 dietary supplement Nutrition 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 5
- 238000010298 pulverizing process Methods 0.000 abstract description 2
- 239000011149 active material Substances 0.000 abstract 1
- 238000007669 thermal treatment Methods 0.000 abstract 1
- 229940088598 enzyme Drugs 0.000 description 72
- 235000000346 sugar Nutrition 0.000 description 50
- 239000012141 concentrate Substances 0.000 description 37
- 235000013824 polyphenols Nutrition 0.000 description 26
- 150000008442 polyphenolic compounds Chemical class 0.000 description 25
- 239000000243 solution Substances 0.000 description 21
- 239000008194 pharmaceutical composition Substances 0.000 description 19
- 238000002360 preparation method Methods 0.000 description 19
- 239000002253 acid Substances 0.000 description 16
- 230000001965 increasing effect Effects 0.000 description 16
- -1 Lee KS Chemical compound 0.000 description 15
- 230000002378 acidificating effect Effects 0.000 description 15
- 241000196324 Embryophyta Species 0.000 description 14
- 230000002292 Radical scavenging effect Effects 0.000 description 14
- 235000006708 antioxidants Nutrition 0.000 description 13
- 230000001954 sterilising effect Effects 0.000 description 13
- 238000004659 sterilization and disinfection Methods 0.000 description 13
- 230000008859 change Effects 0.000 description 12
- 239000004480 active ingredient Substances 0.000 description 11
- 230000036541 health Effects 0.000 description 11
- 230000036737 immune function Effects 0.000 description 11
- 108010059820 Polygalacturonase Proteins 0.000 description 10
- 235000013376 functional food Nutrition 0.000 description 10
- 108010093305 exopolygalacturonase Proteins 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 8
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 8
- 230000002708 enhancing effect Effects 0.000 description 8
- 230000007071 enzymatic hydrolysis Effects 0.000 description 8
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 8
- 241000219357 Cactaceae Species 0.000 description 7
- 108010059892 Cellulase Proteins 0.000 description 7
- 238000002835 absorbance Methods 0.000 description 7
- 229940106157 cellulase Drugs 0.000 description 7
- 239000006071 cream Substances 0.000 description 7
- 101710130006 Beta-glucanase Proteins 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 230000003247 decreasing effect Effects 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- 238000000227 grinding Methods 0.000 description 5
- 239000006210 lotion Substances 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 230000002255 enzymatic effect Effects 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 4
- 229940059442 hemicellulase Drugs 0.000 description 4
- 108010002430 hemicellulase Proteins 0.000 description 4
- 230000001766 physiological effect Effects 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 3
- 102100022624 Glucoamylase Human genes 0.000 description 3
- 108090000604 Hydrolases Proteins 0.000 description 3
- 102000004157 Hydrolases Human genes 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 3
- 102000004139 alpha-Amylases Human genes 0.000 description 3
- 108090000637 alpha-Amylases Proteins 0.000 description 3
- 229940024171 alpha-amylase Drugs 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 230000000975 bioactive effect Effects 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 230000003308 immunostimulating effect Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 235000021419 vinegar Nutrition 0.000 description 3
- 239000000052 vinegar Substances 0.000 description 3
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 208000005189 Embolism Diseases 0.000 description 2
- 101710121765 Endo-1,4-beta-xylanase Proteins 0.000 description 2
- 239000004606 Fillers/Extenders Substances 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- 108010078233 Thymalfasin Proteins 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 235000019219 chocolate Nutrition 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000004042 decolorization Methods 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 239000007884 disintegrant Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000007902 hard capsule Substances 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 239000002955 immunomodulating agent Substances 0.000 description 2
- 229940121354 immunomodulator Drugs 0.000 description 2
- 230000002584 immunomodulator Effects 0.000 description 2
- 229960001438 immunostimulant agent Drugs 0.000 description 2
- 239000003022 immunostimulating agent Substances 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 239000001814 pectin Substances 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- 235000010987 pectin Nutrition 0.000 description 2
- 108010092853 peginterferon alfa-2a Proteins 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 239000007901 soft capsule Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000000375 suspending agent Substances 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- NZVYCXVTEHPMHE-ZSUJOUNUSA-N thymalfasin Chemical compound CC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O NZVYCXVTEHPMHE-ZSUJOUNUSA-N 0.000 description 2
- 229960004231 thymalfasin Drugs 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 239000011345 viscous material Substances 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical class CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 101100264263 Aspergillus awamori xlnD gene Proteins 0.000 description 1
- 206010003645 Atopy Diseases 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 235000011293 Brassica napus Nutrition 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 101710132601 Capsid protein Proteins 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 206010008132 Cerebral thrombosis Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 208000011231 Crohn disease Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- 206010016952 Food poisoning Diseases 0.000 description 1
- 208000019331 Foodborne disease Diseases 0.000 description 1
- 241000626621 Geobacillus Species 0.000 description 1
- 108010023302 HDL Cholesterol Proteins 0.000 description 1
- 229920002488 Hemicellulose Polymers 0.000 description 1
- 241001480714 Humicola insolens Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 102100040018 Interferon alpha-2 Human genes 0.000 description 1
- 108010079944 Interferon-alpha2b Proteins 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 241000077360 Neocrema Species 0.000 description 1
- 206010029098 Neoplasm skin Diseases 0.000 description 1
- 235000004727 Opuntia ficus indica Nutrition 0.000 description 1
- 240000009297 Opuntia ficus-indica Species 0.000 description 1
- 101100541125 Penicillium chrysogenum Xyn gene Proteins 0.000 description 1
- 239000004159 Potassium persulphate Substances 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 206010039085 Rhinitis allergic Diseases 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 102400000800 Thymosin alpha-1 Human genes 0.000 description 1
- 241000223262 Trichoderma longibrachiatum Species 0.000 description 1
- 241001557886 Trichoderma sp. Species 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 241000482268 Zea mays subsp. mays Species 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 201000010105 allergic rhinitis Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 230000002391 anti-complement effect Effects 0.000 description 1
- 108010008730 anticomplement Proteins 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- OIJMIQIDIZASII-UHFFFAOYSA-N benzene;benzoic acid Chemical compound C1=CC=CC=C1.OC(=O)C1=CC=CC=C1 OIJMIQIDIZASII-UHFFFAOYSA-N 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000012050 conventional carrier Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 231100000676 disease causative agent Toxicity 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 244000078673 foodborn pathogen Species 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 150000002314 glycerols Chemical class 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 231100000234 hepatic damage Toxicity 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 235000009200 high fat diet Nutrition 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical class C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229940065638 intron a Drugs 0.000 description 1
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 230000008818 liver damage Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- 201000006417 multiple sclerosis Diseases 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 229940002988 pegasys Drugs 0.000 description 1
- 229960003930 peginterferon alfa-2a Drugs 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- OQUKIQWCVTZJAF-UHFFFAOYSA-N phenol;sulfuric acid Chemical compound OS(O)(=O)=O.OC1=CC=CC=C1 OQUKIQWCVTZJAF-UHFFFAOYSA-N 0.000 description 1
- 235000017807 phytochemicals Nutrition 0.000 description 1
- 235000013550 pizza Nutrition 0.000 description 1
- 229930000223 plant secondary metabolite Natural products 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 description 1
- 235000019394 potassium persulphate Nutrition 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 229940071089 sarcosinate Drugs 0.000 description 1
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229940021747 therapeutic vaccine Drugs 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/324—Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Dermatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Microbiology (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Cosmetics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
본 발명은 천년초 효소 가수분해를 통하여 천년초의 점성을 제거하는 천년초 추출 방법 및 그 방법에 의하여 제조된 천년초 추출물에 관한 것이다.
The present invention relates to a cheonnyeoncho extraction method for removing the viscosity of cheonnyeoncho through enzymatic hydrolysis of cheonnyeoncho and cheonnyeoncho extract prepared by the method.
현재까지 알려진 선인장의 종류는 4,000 여종이 있으며, 탄수화물, 비타민, 미네랄의 공급원으로서 예로부터 식용으로 이용되어 왔다.
There are about 4,000 kinds of cactus known to date, and have been used for food as a source of carbohydrates, vitamins and minerals.
천년초(Opuntia humifusa)는 충남 등지에서 자생하는 한국 토종 선인장으로 일반적으로 손바닥 선인장으로 널리 알려진 백년초(Opuntia ficus-indica var saboten)가 1-2 m 크기로 자라며 길고 굵은 가시가 많은 반면 천년초는 솜털 가시를 갖고 약 30 cm 크기로 자란다. 제주도에서 재배되는 백년초는 열대지방이 원산지로 저온에 약하여 노지재배가 어려운 반면, 한국 토종 선인장인 천년초는 휴면기인 겨울에도 노지에서 생존하며 병충해에 강한 특징이 있다.
Cheonnyeoncho (Opuntia humifusa) is a native Korean cactus that grows in Chungnam and other regions. Opuntia ficus-indica var saboten, commonly known as palm cactus, grows to 1-2 m long and has many long and thick thorns. And grow to about 30 cm in size. Baeknyeoncho, which is grown on Jeju Island, is native to the tropics and is difficult to cultivate in the open field, while Korean native cactus, Chunnyeoncho, survives in the open field even in the dormant winter season, and is resistant to pests.
귀화식물인 백년초에 비하여 천년초의 활성에 대하여는 많은 연구가 이루어지지 않은 편이나, 최근 박 등(Park MK, Lee YJ, Kang ES (2005) Hepatoprotective effect of Cheonnyuncho (Opuntia humifusa) extract in rats treated carbon tetrachloride. J Korean Food Sic Technol 37: 822-826)이 열수에 의한 천년초 줄기 추출물의 항산화 활성 및 사염화탄소로부터 간손상 예방 효과를 보고 하였고, 이 등(Lee KS, Kim MG, Lee KY (2004) Antimicrobial effect of the extracts of cactus Chounnyouncho (Oputia humifusa) against food borne pathogens. J Korean Soc Food Sci Nutr 33: 1268-1272.)은 천년초 선인장 추출물의 항산화 효과 연구에서 천년초의 ethyl acetate 분획물이 α-tocopherol과 비슷한 항산화 활성을 나타낸다고 보고하였으며, 병원성 식중독 미생물에 대하여 천년초 선인장 추출물의 항균 효과가 우수하다고 하였다. 권 및 송(Kwon DK, Song YJ (2005) Effect of opuntia humifusa supplementation on endurance exercise performance in rats fed a high-fat diet. The Korean Journal of Exercise Nutrition 9: 183-188.)은 천년초는 흰쥐의 복부 지방량과 혈중 지질 농도를 감소시키고 HDL-콜레스테롤 농도를 증가시켜 항동맥경화 효과가 있다고 보고 하였으며, 유산소 운동 능력을 향상시킬 수 있는 가능성을 제시한 바 있다. Although much research has not been conducted on the activity of cheonnyeoncho compared to naturalized baeknyeoncho, Park MK, Lee YJ, Kang ES (2005) Hepatoprotective effect of Cheonnyuncho (Opuntia humifusa) extract in rats treated carbon tetrachloride. J Korean Food Sic Technol 37: 822-826) reported the antioxidative activity of cheonnyeoncho stem extracts from hot water and the prevention of liver damage from carbon tetrachloride, including Lee KS, Kim MG, Lee KY (2004) Antimicrobial effect of the Extracts of cactus Chounnyouncho (Oputia humifusa) against food borne pathogens.J Korean Soc Food Sci Nutr 33: 1268-1272.). It was reported that the antimicrobial effect of Cactus extract was excellent against pathogenic food poisoning microorganisms. Kwon DK, Song YJ (2005) Effect of opuntia humifusa supplementation on endurance exercise performance in rats fed a high-fat diet.The Korean Journal of Exercise Nutrition 9: 183-188. It has been reported to have anti-arteriosclerosis effect by reducing hyperlipidemic concentration and increasing HDL-cholesterol concentration, and suggested the possibility of improving aerobic exercise ability.
그러나 백년초가 초콜렛 등 식품으로 활발히 이용되는 반면 천년초는 전술한 생리 활성에도 불구하고 식품, 화장품 등으로 가공, 상용화가거의 이루어지지 않고 있다. 천년초의 가공 및 이용이 활발하지 못한 주된 이유는 천년초의 주성분인 펙틴에 의한 점성 때문으로, 천년초를 이용한 다양한 제품을 개발하기 위하여는 천년초의 소재화를 위한 추출방법이 개선될 것이 우선적으로 요구된다. However, while baeknyeoncho is actively used as food, such as chocolate, cheonnyeoncho is processed and commercialized in food, cosmetics, etc. despite the above-mentioned physiological activity. The main reason why processing and use of millennial plant is not active is due to the viscosity of pectin, which is the main ingredient of millennial plant, and in order to develop various products using millennial plant, it is necessary to improve the extraction method for materialization of millennial plant.
현재까지 천년초의 점성 제거를 위한 시도로는 여과, 효소 가수분해, 발효, 천년초 동결 후 분말화 방법 등이 제시되어 왔는데, 이중 효소 가수분해에 대하여는 천년초의 점성을 완전히 제거할 수 없고, 천년초의 성분을 변화시키므로 부적당하다는 문제점이 있었다(대한민국 등록 특허 제 10-0763797호).
So far, attempts to remove the viscosity of cheonnyeoncho have been proposed for filtration, enzymatic hydrolysis, fermentation, and pulverization after freezing of cheonnyeoncho. For double enzyme enzymatic hydrolysis, cheonnyeoncho cannot be completely removed. There was a problem that it is inappropriate because it changes the (Korean Patent Registration No. 10-0763797).
본 발명의 목적은 천년초의 점성을 효과적으로 제거하는 천년초 추출방법을 제공하는 것이다.It is an object of the present invention to provide a cheonnyeoncho extraction method that effectively removes the viscosity of cheonnyeoncho.
본 발명의 목적은 천년초의 점성이 효과적으로 제거된 천년초 추출물 및 이를 포함하는 조성물을 제공하는 것이다.
It is an object of the present invention to provide a cheonnyeoncho extract and the composition comprising the cheonnyeoncho viscous effectively removed.
상기 목적을 달성하기 위하여 본 발명은 천년초(Pounitia humifusa)에 효소를 가하여 가수분해시켜 천년초의 점성을 제거하는 단계를 포함하는 천년초 추출물의 제조 방법을 제공한다.In order to achieve the above object, the present invention provides a method for preparing a cheonnyeoncho extract comprising the step of removing the viscosity of the cheonnyeoncho by adding an enzyme to the cheonnyeoncho ( Pounitia humifusa ).
또한 본 발명은 상기 제조 방법에 의하여 제조된 천년초 추출물을 제공한다.In another aspect, the present invention provides a cheonnyeoncho extract prepared by the above production method.
아울러 본 발명은 상기 제조 방법에 의하여 제조된 천년초 추출물을 포함하는 조성물을 제공한다.
In addition, the present invention provides a composition comprising the cheonnyeoncho extract prepared by the above method.
본 발명의 천년초 추출물의 제조 방법은 천년초의 점성을 효과적으로 제거하며, 천년초의 생리활성 물질을 높은 수준으로 추출할 수 있다. 또한 천년초 농축액의 수율 또한 종래 추출방법에 비하여 높은 효과가 있다.
The preparation method of the cheonnyeoncho extract of the present invention effectively removes the viscosity of cheonnyeoncho, it is possible to extract the bioactive material of cheonnyeoncho to a high level. In addition, the yield of the cheonnyeoncho concentrate also has a higher effect than the conventional extraction method.
도 1은 가수분해효소에 따른 천년초 효소 가수분해물의 점도를 가리킨다.
도 2는 가수분해효소에 따른 천년초 효소 가수분해물의 총당 및 산성당 함량(을 나타낸다.
도 3은 가수분해 효소에 따른 천년초 효소 가수분해물의 폴리페놀 함량이다.
도 4는 라피데이즈(Rapidase)와 비스코자임(viscozyme) 혼합 사용시 천년초 가수분해물의 점도를 나타낸다(RV-0: 대조군, RV-1(rapidase:viscozyme = 4:0), RV-2(rapidase : viscozyme = 3 : 1), RV-3(rapidase : viscozyme = 2 : 2), RV-4(rapidase : viscozyme = 1 : 3), RV-5(rapidase : viscozyme = 0 : 4)).
도 5는 라피데이즈와 비스코자임 혼합 사용시, 천년초 가수분해물의 총당과 산성당 함량을 나타낸다(RV-0: 대조군, RV-1(rapidase:viscozyme = 4:0), RV-2(rapidase : viscozyme = 3 : 1), RV-3(rapidase : viscozyme = 2 : 2), RV-4(rapidase : viscozyme = 1 : 3), RV-5(rapidase : viscozyme = 0 : 4)).
도 6는 라피데이즈와 비스코자임 혼합액의 처리 시 천년초 추출물의 폴리페놀 함량을 나타낸다(RV-0: 대조군, RV-1(rapidase:viscozyme = 4:0), RV-2(rapidase : viscozyme = 3 : 1), RV-3(rapidase : viscozyme = 2 : 2), RV-4(rapidase : viscozyme = 1 : 3), RV-5(rapidase : viscozyme = 0 : 4)).
도 7은 동량의 물 대비 천년초 첨가량에 따른 천년초 가수분해물의 점도 변화를 나타낸다(CW-1: 물 100 mL에 천년초 100 g첨가, CW-2: 물 100 mL에 천년초 80 g첨가, CW-3: 물 100 mL에 천년초 40 g첨가, CW-4: 물 100 mL에 천년초 20 g첨가).
도 8은 동량의 물 대비 천년초 첨가량에 따른 천년초 가수분해물의 총당 함량 변화를 나타낸다(CW-1: 물 100 mL에 천년초 100 g첨가, CW-2: 물 100 mL에 천년초 80 g첨가, CW-3: 물 100 mL에 천년초 40 g첨가, CW-4: 물 100 mL에 천년초 20 g첨가).
도 9는 천년초 첨가량에 따른 천년초 가수분해물의 산성당 함량 변화를 나타낸다(CW-1: 물 100 mL에 천년초 100 g첨가, CW-2: 물 100 mL에 천년초 80 g첨가, CW-3: 물 100 mL에 천년초 40 g첨가, CW-4: 물 100 mL에 천년초 20 g첨가).
도 10은 동량의 물 대비 천년초 첨가량에 따른 천년초 가수분해물의 폴리페놀 함량 변화를 나타낸다(CW-1: 물 100 mL에 천년초 100 g첨가, CW-2: 물 100 mL에 천년초 80 g첨가, CW-3: 물 100 mL에 천년초 40 g첨가, CW-4: 물 100 mL에 천년초 20 g첨가).
도 11은 천년초 라피데이즈/비스코자임 가수분해물의 가수분해 시간에 따른 점도 변화를 나타낸다.
도 12는 천년초 라피데이즈/비스코자임 가수분해물의 가수분해 시간에 따른 총당 및 산성당 함량 변화를 나타낸다.
도 13은 천년초 라피데이즈/비스코자임 가수분해물의 가수분해 시간에 따른 폴리페놀 함량 변화를 나타낸다.
도 14는 천년초 라피데이즈/비스코자임 가수분해 농축액의 제조공정에 따른 생리활성을 나타낸다.
도 15는 천년초 라피데이즈/비스코자임 가수분해 농축액의 제조공정에 따른 DPPH 라디칼 소거능을 나타낸다.
도 16은 천년초 라피데이즈/비스코자임 가수분해 농축액의 제조공정에 따른 ABTS 라디칼 소거능을 나타낸다. Figure 1 shows the viscosity of the hydrolyzate of cheonnyeoncho according to the hydrolase.
Figure 2 shows the total sugars and acidic sugar content of the millenium distillate enzymatic hydrolyzate according to the hydrolase.
Figure 3 is the polyphenol content of millennial enzyme hydrolyzate according to hydrolase.
Figure 4 shows the viscosity of the millennial hydrolyzate when mixed with Rapidase (viscozyme) (RV-0: control, RV-1 (rapidase: viscozyme = 4: 0), RV-2 (rapidase: viscozyme) = 3: 1), RV-3 (rapidase: viscozyme = 2: 2), RV-4 (rapidase: viscozyme = 1: 3), RV-5 (rapidase: viscozyme = 0: 4)).
Figure 5 shows the total sugar and acidic sugar content of millennial hydrolyzate when mixed with rapidase and biscozyme (RV-0: control, RV-1 (rapidase: viscozyme = 4: 0), RV-2 (rapidase: viscozyme =) 3: 1), RV-3 (rapidase: viscozyme = 2: 2), RV-4 (rapidase: viscozyme = 1: 3), RV-5 (rapidase: viscozyme = 0: 4)).
Figure 6 shows the polyphenol content of cheonnyeoncho extract upon treatment of rapidase and biscozyme mixed solution (RV-0: control, RV-1 (rapidase: viscozyme = 4: 0), RV-2 (rapidase: viscozyme = 3: 1), RV-3 (rapidase: viscozyme = 2: 2), RV-4 (rapidase: viscozyme = 1: 3), RV-5 (rapidase: viscozyme = 0: 4)).
Figure 7 shows the change in the viscosity of the millennial hydrolyzate according to the amount of millennial to the same amount of water compared to the amount of water (CW-1: 100g of millennial to 100 mL of water, CW-2: 80g of millennial to 100mL of water, CW-3: Add 40 g of cheonnyeoncho to 100 mL of water, CW-4: add 20 g of cheonnyeoncho to 100 mL of water).
Figure 8 shows the change in total sugar content of the cheonnyeoncho hydrolyzate according to the amount of cheonnyeoncho compared to the same amount of water (CW-1: added 100g cheonnyeoncho to 100mL of water, CW-2: added 80g of cheonnyeoncho to 100mL of water, CW-3 : 40 g of cheonnyeoncho in 100 mL of water, CW-4: 20 g of cheonnyeoncho in 100 mL of water).
9 shows the acidic sugar content of the millennial hydrolyzate according to the amount of millennial added (CW-1: 100 g of millennial to 100 mL of water, CW-2: 80 g of millennial to 100 mL of water, CW-3: 100 of water) add 40 g of cheonnyeoncho to mL, CW-4: add 20 g of cheonnyeoncho to 100 mL of water).
10 shows the change in the polyphenol content of the millennial hydrolyzate according to the amount of millennial to the same amount of water compared to the amount of water (CW-1: added 100 g of cheonnyeoncho to 100 mL of water, CW-2: added 80 g of cheonnyeoncho to 100 mL of water, CW- 3: add 40 g of cheonnyeoncho to 100 mL of water, CW-4: add 20 g of cheonnyeoncho to 100 mL of water).
FIG. 11 shows the viscosity change with hydrolysis time of Rapidis / Biscocozyme hydrolysates.
Figure 12 shows the change of total sugar and acid sugar content with hydrolysis time of Millipore rapidase / biscozyme hydrolyzate.
Figure 13 shows the change in polyphenol content with hydrolysis time of millennial Rapides / biscozyme hydrolyzate.
Figure 14 shows the physiological activity according to the manufacturing process of rapeseeds / biscozyme hydrolysis concentrate.
Figure 15 shows the DPPH radical scavenging ability according to the manufacturing process of the cheonnyeoncho rapidase / biscozyme hydrolyzate.
Figure 16 shows the ABTS radical scavenging ability according to the manufacturing process of cheonnyeoncho rapidase / biscozyme hydrolyzate.
본 발명은 천년초(Pounitia humifusa)에 효소를 가하여 가수분해시켜 천년초의 점성을 제거하는 단계를 포함하는 천년초 추출물의 제조 방법을 제공한다. 또한 본 발명은 상기 제조방법으로 제조된 천년초 추출물을 제공하며, 상기 천년초 추출물을 포함하는 조성물을 제공한다.
The present invention provides a method of preparing a cheonnyeoncho extract comprising the step of removing the viscosity of the cheonnyeoncho by adding an enzyme to Poyeonia humifusa. In another aspect, the present invention provides a cheonnyeoncho extract prepared by the above method, and provides a composition comprising the cheonnyeoncho extract.
또한 본 발명은 1) 천년초(Pounitia humifusa)를 수세 및 가시 제거하는 단계;2) 수세 및 가시 제거된 천년초에 물을 첨가하여 마쇄하는 단계;3) 마쇄된 천년초에 효소를 처리하고 가수분해하는 단계;4) 열처리하여 효소 활성을 제거하는 단계;5) 단계 4)에서 수득한 천년초 추출액을 여과 또는 원심분리하는 단계;및 6) 단계 5)에서 수득한 여과 또는 원심분리된 천년초 추출액을 농축하는 단계를 포함하는 천년초 추출물의 제조 방법을 제공한다. 또한 본 발명은 상기 제조방법으로 제조된 천년초 추출물을 제공하며, 상기 천년초 추출물을 포함하는 조성물을 제공한다.
In addition, the present invention comprises the steps of: 1) washing and removing thorns of Pounitia humifusa ; 2) rinsing by adding water to rinsed and removed thorns; 3) treating and hydrolyzing enzymes in milled millennials; 4) heat treatment to remove enzyme activity; 5) filtering or centrifuging the millennial extract obtained in step 4); and 6) concentrating the filtered or centrifuged millennial extract obtained in step 5). It provides a method of producing a cheonnyeoncho extract comprising a. In another aspect, the present invention provides a cheonnyeoncho extract prepared by the above method, and provides a composition comprising the cheonnyeoncho extract.
아울러 본 발명은 1) 천년초(Pounitia humifusa)를 수세 및 가시 제거하는 단계;2) 수세 및 가시 제거된 천년초을 마쇄하는 단계;3) 마쇄된 천년초를 주정추출하는 단계; 4) 주정추출한 천년초 추출액을 여과 및 농축하는 단계; 5) 농축된 천년초 추출액에 효소를 처리하고 가수분해하는 단계;및 6) 가수분해된 천년초 추출액을 농축 및 여과하는 단계를 포함하는 천년초 추출물의 제조 방법을 제공한다. 또한 본 발명은 상기 제조방법으로 제조된 천년초 추출물을 제공하며, 상기 천년초 추출물을 포함하는 조성물을 제공한다.
In addition, the present invention comprises the steps of 1) washing and removing thorns of Pounitia humifusa ; 2) grinding and washing off thorns and thorns removed; and 3) extracting crushed millennials; 4) filtering and concentrating the extracted cheonnyeoncho extract; 5) treating and hydrolyzing the enzyme in the concentrated cheonnyeoncho extract; and 6) concentrating and filtering the hydrolyzed cheonnyeoncho extract. In another aspect, the present invention provides a cheonnyeoncho extract prepared by the above method, and provides a composition comprising the cheonnyeoncho extract.
또한 본 발명은 1) 천년초(Pounitia humifusa)에 효소를 가하여 가수분해시켜 천년초의 점성을 제거하는 단계; 및 2) 상기 단계 1)에서 제조한 천년초 추출물을 이용하여 식품 조성물, 약학적 조성물 또는 화장료 조성물을 제조하는 단계를 포함하는 식품 조성물, 약학적 조성물 또는 화장료 조성물의 제조 방법을 제공한다.
In addition, the present invention 1) the step of removing the viscosity of the millennial by hydrolysis by adding the enzyme to Pounitia humifusa ; And 2) preparing a food composition, a pharmaceutical composition or a cosmetic composition using the cheonnyeoncho extract prepared in step 1).
본 발명은 1) 천년초(Pounitia humifusa)를 수세 및 가시 제거하는 단계;2) 수세 및 가시 제거된 천년초에 물을 첨가하여 마쇄하는 단계;3) 마쇄된 천년초에 효소를 처리하고 가수분해하는 단계;4) 열처리하여 효소 활성을 제거하는 단계;5) 단계 4)에서 수득한 천년초 추출액을 여과 또는 원심분리하는 단계; 6) 단계 5)에서 수득한 여과 또는 원심분리된 천년초 추출액을 농축하는 단계; 및 7) 상기 단계 6)에서 제조한 천년초 추출물을 이용하여 식품 조성물, 약학적 조성물 또는 화장료 조성물을 제조하는 단계를 포함하는 식품 조성물, 약학적 조성물 또는 화장료 조성물의 제조 방법을 제공한다.
The present invention comprises the steps of: 1) washing and removing thorns of Pounitia humifusa ; 2) rinsing by adding water to rinsed and removed thorns; 3) treating and hydrolyzing the enzymes in the milled millennials; 4) heat treatment to remove enzyme activity; 5) filtration or centrifugation of the cheonnyeoncho extract obtained in step 4); 6) concentrating the filtered or centrifuged cheonnyeoncho extract obtained in step 5); And 7) preparing a food composition, a pharmaceutical composition or a cosmetic composition using the cheonnyeoncho extract prepared in step 6).
아울러 본 발명은 1) 천년초(Pounitia humifusa)를 수세 및 가시 제거하는 단계;2) 수세 및 가시 제거된 천년초을 마쇄하는 단계;3) 마쇄된 천년초를 주정추출하는 단계; 4) 주정추출한 천년초 추출액을 여과 및 농축하는 단계; 5) 농축된 천년초 추출액에 효소를 처리하고 가수분해하는 단계; 6) 가수분해된 천년초 추출액을 농축 및 여과하는 단계; 및 7) 상기 단계 6)에서 제조한 천년초 추출물을 이용하여 식품 조성물, 약학적 조성물 또는 화장료 조성물을 제조하는 단계를 포함하는 식품 조성물, 약학적 조성물 또는 화장료 조성물의 제조 방법을 제공한다.
In addition, the present invention comprises the steps of 1) washing and removing thorns of Pounitia humifusa ; 2) grinding and washing off thorns and thorns removed; and 3) extracting crushed millennials; 4) filtering and concentrating the extracted cheonnyeoncho extract; 5) treating and hydrolyzing the enzyme in the concentrated millennial extract; 6) concentrating and filtering the hydrolyzed cheonnyeoncho extract; And 7) preparing a food composition, a pharmaceutical composition or a cosmetic composition using the cheonnyeoncho extract prepared in step 6).
또한 본 발명은 상기 식품 조성물, 약학적 조성물 또는 화장료 조성물의 제조 방법을 통하여 제조된 식품 조성물, 약학적 조성물 또는 화장료 조성물을 제공한다.
In another aspect, the present invention provides a food composition, a pharmaceutical composition or a cosmetic composition prepared through the method for producing a food composition, pharmaceutical composition or cosmetic composition.
이하 본 발명을 자세히 설명한다.
Hereinafter, the present invention will be described in detail.
본 발명의 천년초(Pounitia humifusa)는 천년초의 어느 부위이든 상관없다. 천년초의 잎, 줄기, 뿌리 또는 열매 부위를 이용할 수 있으며, 바람직하게는 천년초의 줄기 또는 잎이고, 더욱 바람직하게는 천년초의 줄기이다. 천년초는 수확 직후 곧바로 이용할 수도 있으나, 실온 또는 냉장 보관한 것을 사용할 수도 있고, 동결건조 또는 자연건조한 것을 사용할 수도 있다. 상기 천년초는 편의상 적당한 크기로 세절하거나 분쇄하여 분말 형태로 사용할 수도 있다.
Pounitia humifusa of the present invention may be any part of cheonnyeoncho . A leaf, stem, root or fruit part of the cheonnyeoncho may be used, preferably the cheonnyeoncho stem or leaf, more preferably the cheonnyeoncho stem. Cheonnyeoncho may be used immediately after harvesting, but may be used at room temperature or refrigerated, or may be lyophilized or naturally dried. The cheonnyeoncho may be used in powder form by cutting or grinding to a suitable size for convenience.
본 발명은 천년초에 물을 첨가하여 천년초액을 제조한 후, 여기에 효소를 처리하여 가수분해할 수 있으며, 이때 물 100 mL 당 처리하는 천년초의 질량은 제한되지 않는다. 그러나 천년초의 점성 제거 및 생리활성 물질의 함량을 고려할 때, 물 100 mL 당 천년초 20 내지 100 g을 가하여 효소 가수분해하는 것이 바람직하며, 더욱 바람직하게는 물 100 mL 당 천년초 20 내지 80 g을 가한다. 천년초 추출액의 용도에 따라서 천년초액 제조시 천년초의 양을 조절할 수 있는데, 면역증진용 식품 조성물을 제조하는 경우에는 물 100 mL 당 천년초 20 내지 80 g을 가하여 효소 가수분해하는 것이 산성당 함량을 증가시킬 수 있어 유리하고, 항산화용 식품 조성물을 제조하는 경우에는 물 100 mL 당 천년초 40 내지 80 g을 가하는 것이 폴리페놀 함량을 증가시킬 수 있어서 유리하다. 섭취 시 식감을 좋게 하기 위하여는 물 100 mL 당 천년초 20 내지 40 g을 가하여 효소 분해하는 것이 점성을 완전히 제거할 수 있어서 유리하다. 그러므로 당업자는 천년초 효소 가수분해액의 용도, 경제성, 천년초 가수분해액을 이용한 제품의 제형, 섭취자의 연령 등을 종합적으로 고려하여 효소 처리를 위한 천년초액 제조 시 물과 천년초의 비율을 조절할 수 있다.
According to the present invention, water is added to the millennial plant to prepare the millennial liquor, and the hydrolyzate may be hydrolyzed by treating the enzyme therewith. The mass of millennial plant treated per 100 mL of water is not limited. However, considering the viscosity removal of cheonnyeoncho and the content of physiologically active substance, it is preferable to add 20-100 g of cheonnyeoncho per 100 mL of water to enzymatic hydrolysis, more preferably 20 to 80 g of cheonnyeoncho per 100 mL of water. . The amount of millennial vinegar can be adjusted according to the use of cheonnyeoncho extract.In case of preparing food composition for immunostimulation, enzymatic hydrolysis by adding 20-80 g of cheonnyeoncho per 100mL of water will increase the acid sugar content. It can be advantageous, and in the case of preparing antioxidant food compositions, it is advantageous to add 40-80 g of cheonnyeoncho per 100 mL of water to increase the polyphenol content. In order to improve the texture when ingested, it is advantageous to add 20-40 g of millennial ethanol per 100 mL of water to completely remove the viscosity. Therefore, those skilled in the art can adjust the ratio of water and millennial during the preparation of millennial liquor for enzyme treatment in consideration of the use of the millennial enzymatic hydrolysis solution, the economics, the formulation of the product using the millennial hydrolysate, and the age of the consumer.
본 발명의 효소는 셀룰레이즈(cellulose), 펙티네이즈(pectinase), 헤미셀룰레이즈(hemicellulase), 아라비네이즈(arabinase), 베타-글루카네이즈(beta-glucanase), 자일라네이즈(xylanase), 알파-아밀레이즈(alpha-amylase) 및 글루코아밀레이즈(glucoamylase)로 구성된 군으로부터 선택되는 하나 또는 이들의 혼합물이 될 수 있다. 또한 본 발명의 효소는 비스코자임, 라피데이즈 또는 이들의 혼합물이 될 수 있으며, 바람직하게는 본 발명의 효소는 비스코자임 및 라피데이즈의 혼합물이다. 본 발명의 효소는 더욱 바람직하게는 라피데이즈:비스코자임의 비율이 3:1~1:3인 효소 혼합물이고, 더더욱 바람직하게는 2:2~1:3인 혼합물이고, 가장 바람직하게는 1:3인 혼합물이다. 그러나 이들 효소로 본 발명의 효소가 제한되는 것은 아니며, 천년초를 가수분해할 수 있는 효소면 본 발명에 이용할 수 있다는 것은 당업자에게 자명하다.
Enzymes of the present invention are cellulose, pectinase, hemicellulase, arabinase, beta-glucanase, xylanase, alpha- It may be one or a mixture thereof selected from the group consisting of alpha-amylase and glucoamylase. In addition, the enzyme of the present invention may be biscozyme, rapidides or mixtures thereof, preferably the enzyme of the present invention is a mixture of biscozyme and rapidides. The enzyme of the present invention is more preferably an enzyme mixture in which the ratio of rapidase: biscozyme is 3: 1 to 1: 3, still more preferably a mixture having 2: 2 to 1: 3, and most preferably 1: Mixture of three. However, the enzyme of the present invention is not limited to these enzymes, and it will be apparent to those skilled in the art that any enzyme capable of hydrolyzing cheonnyeoncho can be used in the present invention.
천년초를 가수분해하기 위하여 효소를 처리할 때는 효소의 활성을 높이기 위한 최적의 pH 조건을 유지하는 것이 유리하다. 그러므로 본 발명의 천년초 추출물의 제조방법에 있어서, 천년초에 효소를 가하여 가수분해하는 단계에서 pH 조건은 효소의 종류에 따라 달라질 수 있다는 것은 당업자에게 자명할 것이다. 예컨대, Celulase인 Econitase CE를 가하는 경우 pH 4.0 내지 5.5를 유지하고, 베타-글루카네이즈(Ultraflo L 등)를 이용하는 경우에는 pH 5.5 내지 6.5를 유지하는 것이 적당하다. Rapinase를 이용하는 경우 pH 4.0 내지 5.0을 유지하고, Viscozyme을 이용하는 경우에는 pH 3.3 내지 5.5를 유지하며, Rapinase/Viscozyme 혼합 효소액의 경우에는 pH 4.0 내지 5.0 조건이 바람직하다.
When treating enzymes to hydrolyze cheonnyeoncho, it is advantageous to maintain optimal pH conditions to increase enzyme activity. Therefore, in the preparation method of the cheonnyeoncho extract of the present invention, it will be apparent to those skilled in the art that the pH conditions in the step of hydrolysis by adding the enzyme to cheonnyeoncho may vary depending on the type of enzyme. For example, when adding Celulase Econitase CE, it is appropriate to maintain pH 4.0 to 5.5, and when using beta-glucanase (Ultraflo L, etc.) to maintain pH 5.5 to 6.5. When using Rapinase is maintained at pH 4.0 to 5.0, when using Viscozyme is maintained at pH 3.3 to 5.5, in the case of Rapinase / Viscozyme mixed enzyme liquid pH 4.0 to 5.0 conditions are preferred.
본 발명의 가수분해는 효소를 처리한 후 2시간 이상 수행하는 것이 바람직하다. 더욱 바람직하게는 본 발명의 가수분해는 2시간 내지 16시간 수행하며, 더더욱 바람직하게는 2시간 내지 12시간 수행한다. 2시간 미만으로 가수분해할 경우 천년초의 점성이 완전히 제거되지 않으며, 물 100 mL에 대한 천년초의 함량이 80 g을 초과하는 경우 가수분해 시간이 16시간 이상이 되면 천년초의 점성이 이미 다 제거된 상태이긴 때문에 더 이상 가수분해를 수행할 실익이 적다. 다만 효소처리를 위하여 천년초액을 제조시, 물 100 mL에 대한 천년초의 함량이 60 g 이상인 경우 16시간 동안 가수분해하여야 점성을 완전히 제거할 수 있다. 그러나 12시간을 초과하여 계속하여 가수분해한다고 하여 천년초의 생리활성성분이 유의한 수준으로 증가하는 것이 아니다. 그러므로 당업자는 천년초 추출액의 용도 및 효소처리를 위하여 제조한 천년초 액에 있어서 물에 대한 천년초의 양에 따라서 가수분해 시간을 조절할 수 있다. 예컨대, 효소 처리를 위한 천년초액 제조에 있어 물 100 mL에 대한 천년초의 함량이 0 g을 초과하여 60 g 미만인 천년초 가수분해물을 유효성분으로 포함하는 면역 개선용 건강기능식품을 제조하려는 경우, 가수분해 시간을 2~12시간으로 하는 것이 바람직하며, 천년초 가수분해물을 포함하는 항산화식품을 제조하는 경우, 2~8시간 가수분해하는 것이 바람직하다. 그러나 상기 가수분해 시간 범위 외의 시간 동안 가수분해를 하더라도 2~16시간 동안 가수분해하는 것보다 효과가 떨어지기는 하나 본 발명은 천년초를 효소처리하여 가수분해함으로써 천년초의 점성을 제거하는 것을 특징으로 하는바, 효소 처리하여 2 시간 미만으로 가수분해하거나 16시간을 초과하여 가수분해한다고 하여 본 발명의 범위가 아닌 것은 아니다.
The hydrolysis of the present invention is preferably carried out for 2 hours or more after treating the enzyme. More preferably, the hydrolysis of the present invention is carried out for 2 to 16 hours, even more preferably for 2 to 12 hours. If hydrolysis is less than 2 hours, the viscosity of cheonnyeoncho is not completely removed.If the content of cheonnyeoncho for 100 mL of water exceeds 80 g, the viscosity of cheonnyeoncho is already removed when the hydrolysis time is 16 hours or more. As a result, there is less profit to perform hydrolysis anymore. However, when preparing the millennial liquor for the enzyme treatment, if the content of the millennial to 100 mL of water is more than 60 g to hydrolyze for 16 hours to completely remove the viscosity. However, continuous hydrolysis over 12 hours does not increase the bioactive components of millennial plants to significant levels. Therefore, those skilled in the art can adjust the hydrolysis time according to the use of the millennial extract and the amount of millennial to water in the millennial liquor prepared for the enzyme treatment. For example, in the preparation of millennial liquor for enzyme treatment, if the content of millennial to 100 mL of water is greater than 0 g and contains less than 60 g of cheonnyeoncho hydrolyzate as an active ingredient, to improve health functional food for immune improvement, hydrolysis It is preferable to make time into 2 to 12 hours, and when manufacturing antioxidant food containing a millennial hydrolyzate, it is preferable to hydrolyze for 2 to 8 hours. However, even if the hydrolysis for a time outside the hydrolysis time range is less effective than hydrolysis for 2 to 16 hours, the present invention is characterized by removing the viscosity of the millennial by hydrolysis by hydrolyzing the millennial By enzymatic treatment, hydrolysis in less than 2 hours or in excess of 16 hours is not within the scope of the present invention.
천년초액에 효소를 가하여 가수분해한 후에는 효소의 활성을 상실 및/또는 살균 공정을 거치고 여과 또는 원심분리하여 농축할 수 있다. 이때 효소 활성 상실/살균 공정은 열 살균, 초고온 순간 살균, 고온 단시간 살균, 고온 장시간 살균, 감마선 등을 이용한 방사선 살균, 초고압 살균, 자외선 살균, 초음파 살균, 전자선 살균 또는 화학약품 살균을 이용하여 수행할 수 있으며, 그 외 효소 활성 상실/살균 작용을 하는 것이라면 다른 방법을 이용하여도 무방하다.
After hydrolysis by adding enzyme to the millennial liquor, the activity of the enzyme may be lost and / or sterilized and then concentrated by filtration or centrifugation. At this time, the enzyme activity loss / sterilization process may be performed using thermal sterilization, ultra-high temperature sterilization, high temperature short time sterilization, high temperature long time sterilization, radiation sterilization using gamma rays, ultrahigh pressure sterilization, ultraviolet sterilization, ultrasonic sterilization, electron sterilization or chemical sterilization. In addition, other methods may be used as long as the enzyme activity is lost / sterilized.
본 발명은 천년초(Pounitia humifusa)에 효소를 가하여 가수분해시켜 천년초의 점성을 제거하는 단계를 포함하는 제조 방법을 통하여 제조된 천년초 추출물 및 상기 천년초 추출물을 포함하는 조성물을 제공한다. 또한 1) 천년초(Pounitia humifusa)를 수세 및 가시 제거하는 단계;2) 수세 및 가시 제거된 천년초에 물을 첨가하여 마쇄하는 단계;3) 마쇄된 천년초에 효소를 처리하고 가수분해하는 단계;4) 열처리하여 효소 활성을 제거하는 단계;5) 단계 4)에서 수득한 천년초 추출액을 여과 또는 원심분리하는 단계;및 6) 단계 5)에서 수득한 여과 또는 원심분리된 천년초 추출액을 농축하는 단계를 포함하는 제조 방법을 통하여 제조된 천년초 추출물 및 상기 천년초 추출물을 포함하는 조성물을 제공한다. 또한 본 발명은 1) 천년초(Pounitia humifusa)를 수세 및 가시 제거하는 단계;2) 수세 및 가시 제거된 천년초을 마쇄하는 단계;3) 마쇄된 천년초를 주정추출하는 단계; 4) 주정추출한 천년초 추출액을 여과 및 농축하는 단계; 5) 농축된 천년초 추출액에 효소를 처리하고 가수분해하는 단계;및 6) 가수분해된 천년초 추출액을 농축 및 여과하는 단계를 포함하는 제조방법을 이용하여 제조된 천년초 추출물 및 상기 천년초 추출물을 포함하는 조성물을 제공한다. The present invention provides a cheonnyeoncho extract and a composition comprising the cheonnyeoncho extract prepared through a manufacturing method comprising the step of hydrolyzing by adding an enzyme to Pounitia humifusa to remove the viscosity of cheonnyeoncho . In addition, 1) washing and thorn removal of Pounitia humifusa ; 2) rinsing by adding water to rinse and thorn removal cheonnyeoncho ; 3) treating and hydrolyzing the enzyme in the crushed cheonnyeoncho ; 4) Heat-treating the enzyme activity; 5) filtering or centrifuging the millennial extract obtained in step 4); and 6) concentrating the filtered or centrifuged millennial extract obtained in step 5). It provides a cheonnyeoncho extract and a composition comprising the cheonnyeoncho extract prepared by the manufacturing method. In another aspect, the present invention is 1) washing and thorn removal of Pounitia humifusa ; 2) crushing the rinse and thorn removal cheonnyeoncho; 3) extracting the pulverized cheonnyeoncho; 4) filtering and concentrating the extracted cheonnyeoncho extract; 5) treating and hydrolyzing the enzyme in the concentrated cheonnyeoncho extract; and 6) a composition comprising the cheonnyeoncho extract and the cheonnyeoncho extract prepared using the manufacturing method comprising the step of concentrating and filtering the hydrolyzed cheonnyeoncho extract. To provide.
상기 조성물들은 약학적 조성물, 식품 조성물 또는 화장료 조성물일 수 있으며, 상기 약학적 조성물은 항산화용 약학적 조성물 또는 면역기능 증진용 약학적 조성물일 수 있다. 또한 상기 식품 조성물은 일반 식품, 건강보조식품, 기능성 식품이 될 수 있으며, 간기능 개선용 건강기능식품, 항산화 식품 또는 면역기능 증진용 건강보조식품이 될 수 있다.
The compositions may be a pharmaceutical composition, a food composition or a cosmetic composition, the pharmaceutical composition may be a pharmaceutical composition for antioxidant or a pharmaceutical composition for enhancing immune function. In addition, the food composition may be a general food, health supplement food, functional food, may be a health functional food for improving liver function, antioxidant food or health supplement for immune function enhancement.
천년초 추출물을 포함하는 본 발명의 항산화용 건강기능식품 및 약학적 조성물은 체내 활성산소를 제거함으로써, 체내 지방, 콜레스테롤과 활성산소가 반응하여 과산화지질을 생성하는 것을 저해하고, 이로써, 과산화지질이 혈전, 색전을 생성하는 것을 예방할 수 있다. 또한 본 발명의 항산화용 건강기능식품 및 약학적 조성물은 활성산소를 제거함으로써, 활성산소과 관련된 혈전, 색전, 과산화지질로 인한 혈액순환장애, 뇌졸중, 중풍, 뇌혈전, 심근경색, 동맥경화를 예방 및 치료하고, 활성산소에 의한 DNA, 세포, 조직의 변성을 저해함으로써, 아토피, 알레르기, 종양, 관절염, 백내장, 피부종양을 예방 및 치료하며, 노화진행을 저해한다.
Health functional foods and pharmaceutical compositions for antioxidant of the present invention containing the extract of cheonnyeoncho by removing the active oxygen in the body, inhibits the reaction of fat, cholesterol and free radicals in the body to produce lipid peroxide, whereby the peroxide lipid clots It can prevent the embolism. In addition, antioxidant health functional foods and pharmaceutical compositions of the present invention by removing the active oxygen, blood circulation disorders due to thrombus, embolism, lipid peroxide associated with active oxygen, stroke, stroke, cerebral thrombosis, myocardial infarction, arteriosclerosis and By treating and inhibiting the degeneration of DNA, cells and tissues by free radicals, it prevents and treats atopy, allergy, tumor, arthritis, cataract and skin tumor, and inhibits the aging process.
천년초 추출물을 포함하는 본 발명의 면역기능 증진용 건강기능식품 및 약학적 조성물은 암, 다발성 경화증, 류마티스 관절염, 크론씨병, 당뇨병과 같은 자가면역질환 또는 천식, 알레르기성 비염, 결막염, 아토피 피부염과 같은 알레르기 등 자가면역질환에 효과적이다. 그러나 이런 특정 질환이 아니어도 본 발명의 면역기능 증진용 건강기능식품 및 약학적 조성물은 신체의 전반적인 면역력을 증강시킴으로써 각종 박테리아 및 바이러스성 질환에의 감염 및 발병 가능성을 낮출 수 있다.
Health functional foods and pharmaceutical compositions for improving immune function of the present invention, including the extract of cheonnyeoncho is allergic to cancer, multiple sclerosis, rheumatoid arthritis, Crohn's disease, autoimmune diseases such as diabetes or asthma, allergic rhinitis, conjunctivitis, atopic dermatitis Effective for iso-immune diseases. However, even if not a specific disease, health functional foods and pharmaceutical compositions for enhancing immune function of the present invention may lower the possibility of infection and onset of various bacterial and viral diseases by enhancing the overall immunity of the body.
본 발명의 천년초 추출물을 포함하는 면역기능 개선용 약학적 조성물은 Zadaxin(Thymosinalpha-1), EP-HBS(HBV Therapeutic Vaccine), HBV Core Antigen Vaccine, LPS, Con. A와 같은 면역자극제 또는 Intron A(Interferon alpha-2b), Pegasys(Peginterferon alfa-2a)과 같은 면역조절제와 함께 투약될 수 있다. 또한 본 발명의 면역기능 증진용 약학적 조성물은 상기 면역자극제 또는 면역조절제를 추가로 포함할 수도 있다.
The pharmaceutical composition for improving immune function, including the extract of the present invention cheonnyeoncho is Zadaxin (Thymosinalpha-1), EP-HBS (HBV Therapeutic Vaccine), HBV Core Antigen Vaccine, LPS, Con. It can be administered with an immunostimulant such as A or an immunomodulator such as Intron A (Interferon alpha-2b) or Pegasys (Peginterferon alfa-2a). In addition, the pharmaceutical composition for enhancing immune function of the present invention may further include the immunostimulant or immunomodulator.
본 발명의 항산화용 약학적 조성물 및 면역기능 증진용 약학적 조성물은 경구 또는 비경구로 투여가 가능하며 일반적인 의약품 제제의 형태로 사용될 수 있다. 바람직한 약제학적 제제는 정제, 경질 또는 연질 캅셀제, 액제, 현탁제 등과 같은 경구투여용 제제가 있으며 이들 약제학적 제제는 약제학적으로 허용 가능한 통상의 담체, 예를 들어 경구투여용 제제의 경우에는 부형제, 결합제, 붕해제, 활택제, 가용화제, 현탁화제, 보존제 또는 증량제 등을 사용하여 조제할 수 있다.
The pharmaceutical composition for antioxidant and the immune function enhancing pharmaceutical composition of the present invention can be administered orally or parenterally and can be used in the form of general pharmaceutical preparations. Preferred pharmaceutical preparations include oral preparations such as tablets, hard or soft capsules, solutions, suspensions and the like, which can be used in the form of excipients in conventional pharmaceutically acceptable carriers such as oral preparations, Binders, disintegrants, lubricants, solubilizers, suspending agents, preservatives or extenders can be used.
본 발명의 항산화용 약학적 조성물 및 면역기능 증진용 약학적 조성물의 투여 용량은, 환자의 상태, 연령, 성별 및 합병증 등의 다양한 요인에 따라 전문가에 의해 결정될 수 있지만 일반적으로는 성인 1 kg 당 0.1 ㎎ 내지 10 g, 바람직하게는 10 mg 내지 1 g의 용량으로 투여될 수 있다. 또, 단위 제형당 상기 약학적 조성물의 1일 용량 또는 이의 1/2, 1/3 또는 1/4의 용량이 함유되도록 하며, 하루 1 내지 6 회 투여될 수 있다. 그러나 건강 및 위생을 목적으로 하거나 또는 건강 조절을 목적으로 하는 장기간의 섭취의 경우에는 상기 양은 상기 범위 이하일 수 있으며, 유효성분은 안전성 면에서 아무런 문제가 없기 때문에 상기 범위 이상의 양으로도 사용될 수 있다.
The dosage of the antioxidant composition of the present invention and the pharmaceutical composition for enhancing immune function may be determined by a specialist according to various factors such as the patient's condition, age, sex, and complications, but is generally 0.1 per kg of adult. It may be administered at a dose of mg to 10 g, preferably 10 mg to 1 g. In addition, it is intended to contain a daily dose of the pharmaceutical composition or a dose of 1/2, 1/3 or 1/4 thereof per unit dosage form, and may be administered 1 to 6 times a day. However, in the case of long-term intake for health and hygiene or health control, the amount may be below the above range, and the active ingredient may be used in an amount above the above range because there is no problem in terms of safety.
본 발명의 식품 조성물은 일반 식품, 건강보조식품, 기능성 식품이 될 수 있으며, 항산화 식품 또는 면역기능 증진용 건강보조식품이 될 수 있다. 이때 식품 조성물은 식품 첨가물을 포함한다. 본 발명의 제조방법을 통하여 제조된 천년초 추출물을 포함하는 식품 조성물은 상기 천년초 추출물을 그대로 첨가하거나 다른 식품 또는 식품 조성물과 함께 사용될 수 있으며, 통상적인 방법에 따라 적절하게 사용될 수 있다. 유효 성분의 혼합양은 그 사용 목적(예방, 건강 또는 치료적 처치)에 따라 적합하게 결정될 수 있다. 일반적으로, 본 발명의 식품 조성물은 식품 또는 음료의 제조시에 전체 원료에 대하여 5 내지 70 중량%, 바람직하게는 7 내지 60 중량%의 양으로 첨가될 수 있으나, 풍미, 소비자의 기호, 경제성 등에 따라 그 양을 증감할 수 있다는 것은 당업자에게 자명하다.
The food composition of the present invention may be a general food, health supplement food, functional food, and may be antioxidant food or health supplement food for enhancing immune function. At this time, the food composition includes a food additive. The food composition comprising the cheonnyeoncho extract prepared through the manufacturing method of the present invention may be added as it is or used in conjunction with other food or food compositions, may be appropriately used in accordance with conventional methods. The mixed amount of the active ingredient may be suitably determined according to the purpose of use (prevention, health or therapeutic treatment). In general, the food composition of the present invention may be added in the amount of 5 to 70% by weight, preferably 7 to 60% by weight based on the total raw materials in the manufacture of food or beverage, but the flavor, consumer preferences, economics, etc. It is apparent to those skilled in the art that the amount can be increased or decreased accordingly.
상기 식품의 종류에는 특별한 제한은 없다. 본 발명의 천년초 추출물을 유효성분으로 포함하는 식품 조성물은 정제, 경질 또는 연질 캅셀제, 액제, 현탁제 등과 같은 경구투여용 제제의 형태로 이용될 수 있으며, 이들 제제는 허용 가능한 통상의 담체, 예를 들어 경구투여용 제제의 경우에는 부형제, 결합제, 붕해제, 활택제, 가용화제, 현탁화제, 보존제 또는 증량제 등을 사용하여 조제할 수 있다.There is no particular limitation on the kind of food. The food composition comprising the extract of the cheonnyeoncho as an active ingredient of the present invention can be used in the form of oral administration preparations such as tablets, hard or soft capsules, solutions, suspensions, etc., these preparations are acceptable conventional carriers, such as For example, in the case of oral preparations, excipients, binders, disintegrants, lubricants, solubilizers, suspending agents, preservatives or extenders may be used.
본 발명의 천년초 추출물을 유효성분으로 포함하는 식품의 예로는 육류, 소세지, 빵, 쵸코렛, 캔디류, 스넥류, 과자류, 피자, 라면, 기타 면류, 껌류, 아이스크림류를 포함한 낙농제품, 각종 스프, 음료수, 차, 드링크제, 알콜 음료 및 비타민 복합제 등을 들 수 있으나 이들 종류의 식품으로 제한되는 것은 아니다.
Examples of the food containing the extract of the present invention as an active ingredient, meat, sausage, bread, chocolate, candy, snacks, confectionery, pizza, ramen, other noodles, gums, dairy products including ice cream, various soups, beverages, Teas, drinks, alcoholic beverages, and vitamin complexes, but are not limited to these types of foods.
또한 본 발명은 상기 제조방법에 의하여 제조된 천년초 추출물을 유효성분으로 포함하는 화장료 조성물을 제공하며, 상기 천년초 추출물의 제조 단계를 포함하는 상기 화장료 조성물의 생산 방법을 제공한다. 상기 화장료 조성물의 제조 방법에 있어서, 화장품 제조에 허용되는 담체는 본 발명의 화장료 조성물의 제형에 따라 다를 수 있다. 본 발명의 화장료 조성물의 제형으로는 용액, 현탁액, 유탁액, 페이스트, 젤, 크림, 로션, 비누, 샴푸, 계면활성제-함유 클렌징, 오일, 분말 파운데이션, 리퀴드 파운데이션, 크림 파운데이션 및 스프레이 등으로 제형화 될 수 있으며, 본 발명의 항산화용 화장료 조성물은 보다 상세하게는 유연 화장수(스킨, 토너), 수렴 화장수, 영양 화장수(로션), 영양 크림, 마사지 크림, 에센스, 젤, 피부 접착용 패치, 파우더, 피부외용연고, 첩포제, 현탁액, 에멀젼 스프레이, 아이 크림, 클렌징 크림, 클렌징 폼, 클렌징 위터, 팩, 헤어 에센스 또는 미용액 등의 통상의 화장료 형태로 제조될 수 있다.In another aspect, the present invention provides a cosmetic composition comprising the cheonnyeoncho extract prepared by the manufacturing method as an active ingredient, and provides a production method of the cosmetic composition comprising the manufacturing step of the cheonnyeoncho extract. In the manufacturing method of the cosmetic composition, the carrier that is acceptable for the manufacture of cosmetics may vary depending on the formulation of the cosmetic composition of the present invention. The cosmetic compositions of the present invention may be formulated into solutions, suspensions, emulsions, pastes, gels, creams, lotions, soaps, shampoos, surfactant-containing cleansing, oils, powder foundations, liquid foundations, cream foundations, sprays, and the like. The antioxidant cosmetic composition of the present invention may be more specifically a flexible lotion (skin, toner), astringent lotion, nutrition lotion (lotion), nutrition cream, massage cream, essence, gel, skin adhesive patch, powder, It may be prepared in the form of a conventional cosmetic such as skin external ointment, patch, suspension, emulsion spray, eye cream, cleansing cream, cleansing foam, cleansing butter, pack, hair essence or essence.
상기 본 발명의 제조방법에 의해 제조된 화장료 조성물의 제형이 페이스트, 크림 또는 젤의 경우 담체 성분으로는 동물성 유, 식물성 유, 왁스, 파라핀, 전분, 트라킨트, 셀룰로오스 유도체, 폴리에틸렌 글리콜, 실리콘, 벤토나이트, 실리카, 탈크 또는 산화아연 등이 바람직하다.When the formulation of the cosmetic composition prepared by the method of the present invention is a paste, cream or gel, the carrier component is animal oil, vegetable oil, wax, paraffin, starch, trachant, cellulose derivative, polyethylene glycol, silicone, bentonite , Silica, talc or zinc oxide and the like are preferred.
상기 본 발명의 제조방법에 의해 제조된 천년초 추출액을 유효성분으로 포함하는 화장료 조성물의 제형이 용액 또는 유탁액인 경우 담체 성분으로는 용매, 용매화제 또는 유탁화제가 이용될 수 있으며, 그의 예로서는 물, 에탄올, 이소프로판올, 에틸 카보네이트, 에틸 아세테이트, 벤젠 알코올, 벤젠 벤조에이트, 프로필렌 글리콜, 1,3-부틸글리콜 오일, 글리세롤 지방족 에스테르, 폴리에틸렌 글리콜 또는 소르비탄의 지방산 에스테르 등이 바람직하다.When the formulation of the cosmetic composition comprising the cheonnyeoncho extract prepared by the preparation method of the present invention as an active ingredient is a solution or emulsion, a carrier, a solvating agent or an emulsifying agent may be used as a carrier component, and examples thereof include water, Preferred are ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzene alcohol, benzene benzoate, propylene glycol, 1,3-butylglycol oil, glycerol aliphatic ester, polyethylene glycol or fatty acid ester of sorbitan.
상기 본 발명의 제조방법에 의해 제조된 천년초 추출액의 제형이 현탄액의 경우 담체 성분으로는 물, 에탄올 또는 프로필렌 글리콜과 같은 액상의 희석제, 에톡실화 이소스테아릴 알코올, 알루미늄 메타히드록시드, 벤토나이트, 아가 또는 트라칸트 등이 바람직하다.In the case of the suspension of the cheonnyeoncho extract prepared by the production method of the present invention is a suspension solution, the carrier component is water, ethanol or liquid diluents such as propylene glycol, ethoxylated isostearyl alcohol, aluminum metahydroxy, bentonite, Agar or tracant and the like are preferable.
상기 본 발명의 제조방법에 의해 제조된 화장료 조성물의 제형이 계면 활성제 함유 클린징인 경우에는 담체 성분으로는 지방족 알코올 설페이트, 지방족 알코올 에테르설페이트, 설포숙신산 모노에스테르, 이세티오네이트, 이미다졸리늄 유도체, 메틸타우레이트, 사르코시네이트, 지방산 아미드 에테르 설페이트, 알킬아미도베타인, 지방족 알코올, 지방산 글리세리드, 지방산 디에탄올아미드, 식물성 유, 라놀린 유도체 또는 에톡실화 글리세롤. 지방산 에스테르 등이 바람직하다
When the formulation of the cosmetic composition prepared by the preparation method of the present invention is a surfactant-containing cleansing, the carrier component may be aliphatic alcohol sulfate, aliphatic alcohol ether sulfate, sulfosuccinic acid monoester, isethionate, imidazolinium derivative, Methyltaurate, sarcosinate, fatty acid amide ether sulfate, alkylamidobetaine, fatty alcohols, fatty acid glycerides, fatty acid diethanolamides, vegetable oils, lanolin derivatives or ethoxylated glycerol. Fatty acid esters and the like are preferred.
이하, 본 발명을 다음의 실시예 및 실험예에 의하여 보다 상세하게 설명한다. 단, 하기 실시예 및 실험예는 본 발명의 내용을 예시하는 것일 뿐 발명의 범위가 실시예 및 실험예에 의해 한정되는 것은 아니다.
Hereinafter, the present invention will be described in more detail by the following examples and experimental examples. However, the following Examples and Experimental Examples are only illustrative of the contents of the present invention and the scope of the invention is not limited by the Examples and Experimental Examples.
<실시예 1> 재료
Example 1 Materials
본 실험에 사용된 천년초는 충남 연기군에서 생산된 것으로 네오크레마로부터 제공받았다. 선인장의 점성 물질의 분해를 위하여는 셀룰레이즈(Econitase CE), 베타-글루카네이즈(Ultralflo L), 펙티네이즈(Cytolase PCL 5), 알파-아밀레이즈(Spezyme Prime), 글루코아밀레이즈(Optidex L-400), Pectinex 5XL, Celluclast 1.5L, optidex L-400, 효소 혼합물인 Rapidase(펙티네이즈, 헤미셀룰레이즈 및 셀룰레이즈) 및 Viscozyme(아라비네이즈, 셀룰레이즈, 베타-글루카네이즈, 헤미셀룰레이즈 및 자일레이즈)를 사용하였으며 이들은, 비전바이오캠으로부터 구입하였다(표 1).
Cheonnyeoncho used in this experiment was produced in Chungnam Yeongi-gun and received from Neo-Crema. For the decomposition of viscous substances of cactus, cellulase (Econitase CE), beta-glucanase (Ultralflo L), pectinase (Cytolase PCL 5), alpha-amylase (Spezyme Prime), glucoamylase (Optidex L- 400), Pectinex 5XL, Celluclast 1.5L, optidex L-400, Enzyme mixture Rapidase (pectinase, hemicellulose and cellulase) and Viscozyme (arabinase, cellulase, beta-glucanase, hemicellulase and xyl Raise), which were purchased from Vision Biocam (Table 1).
Enzyme
Enzyme
Main activity
Main activity
Source
Source
Optimum condition
Optimum condition
pH
pH
Temp (℃)
Temp (℃)
Econitase CE
Econitase CE
Cellulase
Cellulase
Trichoderma sp.
Trichoderma sp.
4.0-5.5
4.0-5.5
55
55
Rapidase
Rapidase
pectinase, hemicellulase,
cellulase
pectinase, hemicellulase,
cellulase
Asp . niger & T. longibrachiatum
Asp . niger & T. longibrachiatum
4.0-5.0
4.0-5.0
10-55
10-55
Viscozyme
Viscozyme
arabinase, cellulase, β-glucanase,
hemicellulase, xylanase
arabinase, cellulase, β-glucanase,
hemicellulase, xylanase
Asp. Sp.
Asp . Sp.
3.3-5.5
3.3-5.5
40-50
40-50
Ultraflo L
Ultraflo L
β-glucanase
β-glucanase
HumicolaHumicola
insolensinsolens
6
6
40
40
Cytolase PCL 5
pectinase
pectinase
AspAsp
. .
NigerNiger
2.5-5.0
2.5-5.0
10-55
10-55
Spezyme Prime
Spezyme prime
α-amylase
α-amylase
AspAsp
. .
nigerniger
6.2-6.5
6.2-6.5
85-90
85-90
Optidex L-400
Optidex L-400
glucoamylase
glucoamylase
Geobacillus
stearothermophilus
Geobacillus
stearothermophil us
4.0-4.5
4.0-4.5
58-65
58-65
Celluclast 1.5L
Celluclast 1.5L
cellulase
cellulase
TrichdermaTrichderma
reeseireesei
4.5-6.0
4.5-6.0
50-60
50-60
Pectinex 5XL
Pectinex 5XL
polygalacturonase
polygalacturonase
AspAsp
. .
nigerniger
4.5
4.5
50
50
효소의 특성
Characteristics of the enzyme
<실시예 2> 천년초 효소 가수분해물의 활성 분석Example 2 Activity Analysis of Enzyme Hydrolysates
<실험예 1> 천년초 효소 가수분해물의 제조Experimental Example 1 Preparation of Enzyme Hydrolysates
천년초의 줄기를 수세 후 잔가시를 제거한 다음 천년초 70 g에 물 700 mL을 가하여 homeogenizer 로 마쇄하였다. 이를 70mL씩 나누고 각각 ultraflo L, Viscozyme, Spezyme prime, Cytolase PCL5, Celluclast 1.5L, Optidex L-400, Pectinex 5XL, Rapidase 및 Econase CE를 가하고(효소 첨가량: 350 μL), 40℃ 에서 6시간 서서히 교반하면서 가수분해를 하였다. 그 후, 끓는 물에 5분간 가열 처리하여 효소 활성을 제거하고, 냉각 및 여과하여 그 상징액을 천년초 효소 가수분해액으로 사용하였다.
After rinsing the stem of Cheonnyeoncho, the residual residue was removed, and 700 mL of water was added to 70 g of Cheonnyeoncho and crushed with a homeogenizer. Divide 70 mL each, add ultraflo L, Viscozyme, Spezyme prime, Cytolase PCL5, Celluclast 1.5L, Optidex L-400, Pectinex 5XL, Rapidase and Econase CE (addition amount of enzyme: 350 μL), and slowly stir at 40 ° C for 6 hours. Hydrolysis was carried out. Thereafter, the mixture was heated in boiling water for 5 minutes to remove enzyme activity, cooled, and filtered to use the supernatant as a millennial enzyme hydrolysis solution.
<실험예 2> 천년초 효소 가수분해물의 활성 분석Experimental Example 2 Activity Analysis of Enzyme Hydrolysates
점도Viscosity
Brookfield viscometer(Model DV-II)를 이용하여 천년초 효소 가수분해물의 점성을 측정하였으며, 이때 spindle No. 3을 사용하여 30 °C에서 60 rpm의 조건에서 점도를 측정하였다(도 1).The viscosity of enzymatic hydrolysates was measured using a Brookfield viscometer (Model DV-II). The viscosity was measured under the conditions of 60 rpm at 30 ° C using 3 (Fig. 1).
천년초의 점성은 주로 펙틴 때문이므로, 펙티네이즈(cytolase PCL5) 처리 시 점도가 제일 많이 낮아질 것으로 예상하였으나 점도 측정 결과, 펙티네이즈는 다른 효소들에 비하여 점성 제거 효과가 유의하게 높지는 않았으며(Cytoclase PCL5 처리 시 점도: 13.60 cP), 전분 분해효소인 spezyme prime과 optidex L-400은 점성이 대조군(14.47 cP)보다 오히려 약간 증가하는 것이 확인되었다(각각 14.77과 15.47 cP). 특히, 펙티네이즈가 포함되어 있지 않은 비스코자임(Viscozyme) 처리 시 천년초 추출액의 점도가 상당히 낮아졌으며(12.87 cP), 라피데이즈(Rapidase) 처리군의 점도는 12.67 cP로 효소 가수분해군들 중 가장 낮은 점도를 보였다.
Since the viscosity of cheonnyeoncho was mainly due to pectin, it was expected that the viscosity would be the lowest when treating pectinase (cytolase PCL5). However, the results of viscosity measurement showed that pectinase did not have a significantly higher viscosity removal effect than other enzymes (Cytoclase PCL5). Viscosity at treatment: 13.60 cP), starch degrading enzymes spezyme prime and optidex L-400 were found to increase slightly in viscosity rather than control (14.47 cP) (14.77 and 15.47 cP, respectively). In particular, Viscozyme treatment without pectinase significantly lowered the viscosity of the cheonnyeoncho extract (12.87 cP), and the viscosity of the Rapidase treatment group was 12.67 cP, the lowest among the enzyme hydrolysis groups. It showed a viscosity.
총당 및 산성당 함량 Total sugar and acid sugar content
phenol-sulfuric acid법과 Blumenkrantz과 Asboe-Hansen법(Blumenkrantz, N. and Asboe-Hansen, G. (1973) Anal. Biochem., 54, 484)을 이용하여, 천년초 효소 가수분해물의 총당과 산성당의 함량을 측정하였다.
The total and acidic sugar contents of the enzymatic hydrolysates of cheonnyeoncho were determined using the phenol-sulfuric acid method and Blumenkrantz and Asboe-Hansen methods (Blumenkrantz, N. and Asboe-Hansen, G. (1973) Anal. Biochem., 54, 484). Measured.
그 결과, 대조군의 총당 및 산성당의 함량은 각각 14.2 mg/mL, 461.0 mg/mL인 반면, 셀루클라스트 1.5L(celluclast 1.5L)에 의한 가수분해물은 35.7 mg/mL, 564.5 mg/mL으로 가장 높은 함량을 보였으며, 점도가 가장 낮았던 비스코자임과 라피데이즈의 가수분해물의 경우 총당은 24.0, 16.9 mg/mL, 산성당은 각각 468.6, 558.4 mg/mL이었다. 산성당은 에코네이즈 CE(econase CE)에 의한 가수분해물이 가장 높은 638.4 mg/mL이었으나, 총당의 함량은 15.0 mg/mL로 가장 낮은 수준이었다(도 2).
As a result, the total and acid sugar contents of the control group were 14.2 mg / mL and 461.0 mg / mL, respectively, while the hydrolyzate by 1.5L of celluclast was 35.7 mg / mL and 564.5 mg / mL, respectively. The highest content of biscozyme and rapidase hydrolyzate was 24.0, 16.9 mg / mL and 468.6 and 558.4 mg / mL, respectively. The acidic sugar was 638.4 mg / mL having the highest hydrolyzate by econase CE, but the lowest total sugar content was 15.0 mg / mL (FIG. 2).
폴리페놀Polyphenols
Folin-Denis 법(Dewanto, V., Wu, X., & Liu, R. H. (2002b). Processed sweet corn has higher antioxidant activity. Journal of Agricultural and Food Chemistry, 50, 4959-4964.)에 의하여 천년초 효소 가수분해물의 폴리페놀 함량을 측정하였다.
Millenium Enzyme Singer by Folin-Denis Method (Dewanto, V., Wu, X., & Liu, RH (2002b) .Processed sweet corn has higher antioxidant activity.Journal of Agricultural and Food Chemistry, 50, 4959-4964.) The polyphenol content of the degradation product was measured.
천년초 효소 가수분해물들은 모두 대조군(37.8 mg/mL)에 비하여 2.5 내지 4 배 높은 폴리페놀을 함유하였다(도 3). 그 중 펙티네이즈인 사이토클레이즈 PCL5(Cytoclase PCL5) 가수분해물의 폴리페놀 함량이 가장 높았으며(154. 0 mg/mL), 울트라플로(Ultraflo L), 비스코자임, 스페자임 프라임(Spezyme prime), 펙티넥스 5XL(Pectinex 5XL) 및 라피데이즈는 120 ~ 140 mg/mL의 폴리페놀을 함유하였다.
All millennial enzyme hydrolyzates contained 2.5-4 times higher polyphenols compared to the control (37.8 mg / mL) (FIG. 3). Among them, the polyphenol content of pectinase, Cytoclase PCL5 hydrolyzate, was the highest (154.0 mg / mL), Ultraflo L, Biscozyme, Spezime prime, Pectinex 5XL and Rapidases contained 120-140 mg / mL polyphenols.
<실시예 3> 천년초 비스코자임/라피데이즈 가수분해물의 활성 분석Example 3 Activity Analysis of Bichonzyme / Rapidase Hydrolysates
실시예 2의 결과에 의해 총당, 산성당의 함량이 비교적 높으며, 점도가 가장 낮은 라피데이즈와 비스코자임을 선정하고, 이들의 혼합 효소액을 처리하여 천년초 가수분해물을 제조하였다.As a result of Example 2, the contents of total sugar and acid sugar were relatively high, and the rapid viscosity and biscozyme having the lowest viscosity were selected, and hydrolyzate was prepared by treating their mixed enzyme solution.
<실험예 1> 천년초 비스코자임/라피데이즈 가수분해물의 제조Experimental Example 1 Preparation of Bichonzyme / Rapidase Hydrolysates
점도가 가장 낮았던 비스코자임과 라피데이즈를 혼합 사용에 따른 효과를 측정하고자, 천년초 100 g에 물 500 mL을 가하여 마쇄 후, 효소(효소5 mL/100 g천년초)를 첨가하여 40℃ 에서 9시간동안 가수분해 하였다. 이때 첨가한 효소는 라피데이즈와 비스코자임을 각각 4:0, 3:1, 2:2, 1:3과 0:4의 비율로 첨가하여 가수분해물을 제조하였다.
In order to measure the effect of the mixture of biscozyme and rapidase, which had the lowest viscosity, 500 ml of water was added to 100 g of cheonnyeoncho and crushed, followed by addition of enzyme (5 mL / 100 g cheonnyeoncho) for 9 hours at 40 ° C. Hydrolysis. At this time, the enzymes were added to Rapidase and biscozyme in the ratio of 4: 0, 3: 1, 2: 2, 1: 3 and 0: 4, respectively, to prepare a hydrolyzate.
RV-1 내지 RV-5: 라피데이즈 : 비스코자임의 비율RV-1 to RV-5: Rapides: Biscozyme ratio
RV-0: 대조군(천년초 열수 추출물)
RV-0: control (millennial hydrothermal extract)
<실험예 2> 천년초 비스코자임/라피데이즈 가수분해물의 활성 분석Experimental Example 2 Activity Analysis of Biscozyme / Rapidase Hydrolysates
점도Viscosity
라피데이즈와 비스코자임의 혼합 효소액을 가한 경우, 대조군(10.07 cP)에 비하여 점도가 현저히 감소하는 것이 확인되었다. Viscozyme만을 처리하였을 때(RV-5, 2.50 cP)의 점도는 Rapidase만을 처리하였을 때(RV-1)보다 높았으나, 이들을 특정 비율로 혼합 시 점도가 낮아졌으며(RV-3 및 RV-4), 특히 라피데이즈 : 비스코자임을 1:3으로 혼합 시 점도가 가장 낮아졌는바(RV-4. 1.25CP), 이는 라피데이즈와 비스코자임를 특정 비율로 혼합하여 처리 시, 천년초 추출액의 점성을 효과적으로 제거할 수 있다는 것을 의미한다(도 4).
When the mixed enzyme solution of rapidase and biscozyme was added, it was confirmed that the viscosity was significantly reduced compared to the control (10.07 cP). The viscosity of Viscozyme alone (RV-5, 2.50 cP) was higher than that of Rapidase only (RV-1), but when they were mixed at a specific ratio, the viscosity was lower (RV-3 and RV-4). In particular, Rapids: Biscozyme 1: 3 was the lowest viscosity when mixed (RV-4.25CP), which can effectively remove the viscosity of the cheonnyeoncho extract during treatment by mixing Rapidis and Biscozyme in a specific ratio. It means that it can (Fig. 4).
총당 및 산성당 함량 Total sugar and acid sugar content
혼합 사용시의 총당과 산성당의 함량을 측정한 결과(그림 5), 라피데이즈와 비스코자임의 혼합 효소액 처리군은 대조군에 비하여 총당 및 산성당 함량이 높은 것으로 확인되었다. 총당의 함량은 RV-4에서 가장 높은 18.5 mg/mL이었으며, 대조군은 12.3 mg/mL이었다. 산성당인 uronic acid함량은 대조군이 1.27 mg/mL인 반면, RV-1 및 RV-4는 각각 1.94 mg/mL 및 1.95 mg/mL의 높은 함량을 보였다. 총당 및 산성당 함량은 모두 점도가 제일 낮은 RV-4가 제일 높았다.
As a result of measuring the total sugar and acid sugar content in the mixed use (Fig. 5), the mixed enzyme solution of rapidase and biscozyme was found to have higher total and acid sugar content than the control group. The total sugar content was the highest at 18.5 mg / mL in RV-4 and the control group was 12.3 mg / mL. The uric acid content of the acidic sugar was 1.27 mg / mL in the control group, whereas RV-1 and RV-4 showed high contents of 1.94 mg / mL and 1.95 mg / mL, respectively. The total and acidic sugar contents of RV-4, which had the lowest viscosity, were the highest.
폴리페놀Polyphenols
대조군의 폴리페놀의 함량이 제일 낮았으며(34.62 mg/mL), 라피데이즈와 비스코자임를 혼합 사용시 98.31-106.81 mg/mL 함량을 보였으나, 효소의 혼합 비율간에 유의적인 차이는 없었다(도 6).
The content of polyphenols in the control group was the lowest (34.62 mg / mL) and 98.31-106.81 mg / mL when rapidase and biscozyme were mixed, but there was no significant difference between the mixing ratios of enzymes (FIG. 6).
이상의 결과들을 종합할 때, 라피데이즈와 비스코자임을 1 : 3의 비율로 혼합한 효소 혼합액을 천년초에 가할 경우, 천년초 추출액의 점성을 가장 효과적으로 제거할 수 있었으며, 총당, 산성당 및 폴리페놀 등 천년초의 유효성분의 함량도 높은 것을 알 수 있었다.
In summary, when the enzyme mixture mixed with Rapidis and biscozyme in a ratio of 1: 3 was added to the millennial plant, the viscosity of the millennial extract was most effectively removed, and the millennial plant such as total sugar, acid sugar, and polyphenol It can be seen that the content of the active ingredient is also high.
<실시예 4> 천년초 첨가량에 따른 천년초 비스코자임/라피데이즈 가수분해물의 활성Example 4 Activity of Biscozyme / Rapidase Hydrolysates with Millennial Addition
라피데이즈와 비스코자 혼합액을 처리하여 천년초 가수분해물을 제조 시, 가수분해물의 점도, 총당, 산성당 및 폴리페놀의 함량을 측정하여, 첨가되는 천년초 양에 따른 천년초 가수분해물의 활성을 측정하였다.
During the preparation of the millennial hydrolyzate by treating the mixed solution with Rapidis and biscoza, the hydrolyzate, total sugar, acidic sugar and polyphenol content were measured to determine the activity of the millennial hydrolyzate according to the amount of millennial added.
<실험예 1> 가수분해물의 제조Experimental Example 1 Preparation of Hydrolyzate
천년초 20, 40, 80 및 100g에 물 100 mL을 가하여 마쇄한 후, 라피데이즈/비스코자임 혼합 효소액(1:3 혼합)을 첨가하여(천년초 100 g 당 효소액 5 mL) 40℃ 에서 12 시간 동안 가수분해하였다.
Crushed by adding 100 mL of water to 20, 40, 80, and 100 g of Cheonnyeoncho, and adding rapidase / biscozyme mixed enzyme solution (1: 3 mixture) (5 mL of enzyme solution per 100 g of millennial plant) for 12 hours. Digested.
CW-1
CW-1
CW-2
CW-2
CW-3
CW-3
CW-4
CW-4
천년초의 양
(g/물 100mL)
Amount of millennial
(g /
100
100
80
80
40
40
20
20
<실험예 2> 천년초 첨가량에 따른 활성 분석<Experimental Example 2> Activity analysis according to the amount of cheonnyeoncho added
점도Viscosity
가수분해 전에는 천년초 양이 많을수록 점도가 유의하게 높았으나, 라피데이즈/비스코자임 혼합 효소액 (1:3 혼합)을 처리하자 급격히 점도가 감소하였다. 특히 물 100 mL에 천년초 20 g 첨가군(CW-4)은 점성물질이 완전히 제거되었으며, 천년초 40 g 첨가군(CW-3)은 점성이 거의 제거되었다(도 7).
Prior to hydrolysis, the higher the amount of millennial plants, the higher the viscosity. However, the viscosity rapidly decreased after treatment with Rapidase / biscozyme mixed enzyme solution (1: 3 mixture). In particular, 100 g of water and 20 g of Cheonnyeoncho (CW-4) completely removed the viscous material, and 40 g of Cheonnyeoncho (CW-3) almost eliminated the viscosity (FIG. 7).
총당 및 산성당 함량 Total sugar and acid sugar content
동일한 양의 물에 천년초 첨가량을 달리하여 가수분해 시, 총당과 산성당의 함량을 측정한 결과, 가수분해 전에 비해 가수분해 후에 총당과 산성당의 함량이 증가하는 것이 확인되었다. 가수분해 후 총당량은 천년초 100g 첨가군(CW-1)이 제일 많고, 20g 첨가군(CW-4)이 제일 적었지만, CW-2 및 CW-3은 총당량에 유의한 차이가 없었다(도 8). 반면 산성당의 함량은 천년초 첨가량에 비례하여 증가하는 경향을 보였다(그림 9). 그러므로 천년초 첨가량은 천년초 가수분해물의 용도에 따라서 결정하는 것이 바람직할 것으로 보인다. 예컨대, 천년초 가수분해물을 유효성분으로 포함하는 면역 증진용 건강보조식품의 경우, 산성당의 함량이 높을수록 유리한바, 물의 양에 비하여 천년초를 많이 첨가하여 효소 처리하는 것이 바람직하다.
As a result of measuring the content of total sugar and acidic sugar during hydrolysis by varying the amount of millennial added to the same amount of water, it was confirmed that the content of total sugar and acidic sugar increased after hydrolysis compared to before hydrolysis. After hydrolysis, the total equivalent weight of 100g (CW-1) and the most added 20g (CW-4) were the lowest, but CW-2 and CW-3 had no significant difference in total equivalents (Fig. 8). On the other hand, the content of acidic sugars tended to increase in proportion to the amount of millennial added (Figure 9). Therefore, it may be desirable to determine the amount of millennial added according to the use of the millennial hydrolyzate. For example, in the case of the dietary supplement for immune enhancement comprising a cheonnyeoncho hydrolyzate as an active ingredient, the higher the content of acidic sugar is advantageous, it is preferable to add a lot of cheonnyeoncho compared to the amount of water to treat the enzyme.
폴리페놀Polyphenols
폴리페놀의 함량은 가수분해 전에는 천년초의 첨가량 40 g이하일 경우 천년초의 첨가량이 증가할수록 폴리페놀의 함량이 증가하였으나, 40 g이상의 양을 첨가하였을 경우 폴리페놀의 양은 거의 비슷하였다. 반면에, 효소 가수분해 후의 폴리페놀의 함량은 천년초 첨가량이 증가할수록 증가하는 경향을 보였다(도 10).
The content of polyphenol was increased when the amount of polyphenol was increased below 40 g before the hydrolysis, but the amount of polyphenol was about the same when the amount of polyphenol was added more than 40 g. On the other hand, the content of polyphenols after enzymatic hydrolysis showed a tendency to increase as the amount of millennial added increased (FIG. 10).
상기 결과들을 종합하면, 효소 가수분해를 위한 천년초액의 제조시, 동일한 양의 물에 포함되는 천년초의 함량이 증가할수록 가수분해물의 생리활성 물질이 증가하는 경향을 보였으나, 총당의 함량은 천년초 첨가량과 비례하지는 않았다. 그러므로 천년초 가수분해물의 용도 및 수요자의 요구(가격, 효과 정도 등)에 따라 천년초의 첨가량을 조절하여 가수분해하는 것이 바람직하다.
Taken together, the preparation of millennial liquor for enzymatic hydrolysis showed a tendency to increase the bioactive substance of hydrolyzate as the amount of millennial herb contained in the same amount of water increased. It is not proportional to. Therefore, it is preferable to hydrolyze the amount of millennial plant by adjusting the amount of millennial plant hydrolyzate according to the use of the hydrolyzate and the demand of the consumer (price, degree of effect, etc.).
<실시예 5> 가수분해 시간에 따른 천년초 라피데이즈/비스코자임 가수분해물의 활성Example 5 Activity of Millipore Rapids / Biscocozyme Hydrolysates with Hydrolysis Time
천년초 100 g에 물 100 mL을 가하여 마쇄한 후 여기에 라피데이즈/비스코자임 혼합액(1:3의 비율로 혼합)을 첨가(천년초 100 g당 효소액 5 mL)하여 40℃ 에서 시간을 달리하여 가수분해하였다.
100 mL of water was added to 100 g of cheonnyeoncho and crushed, and then mixed with Rapids / Biscocozyme (mixed at a ratio of 1: 3) (5 mL of enzyme solution per 100g of cheonnyeoncho) and hydrolyzed at different temperatures at 40 ° C. It was.
점도Viscosity
가수분해 시간에 따른 점도의 변화를 측정한 결과(도 11), 가수분해 전 40.9 cP의 점도를 보였던 천년초는 가수분해 2시간 후에 1.9 cP로 점도가 급격히 감소하였으며, 그 이후에는 점도가 서서히 감소하여 가수분해 11시간 이후에는 점도가 측정되지 않을 정도로 완전히 분해되었다. 그러므로 2시간 이상 가수분해하는 것이 천년초 추출액의 점성을 제거하는데 효과적으로 판단된다.
As a result of measuring the change in viscosity according to the hydrolysis time (FIG. 11), the millennial plant showed a viscosity of 40.9 cP before hydrolysis, and the viscosity decreased rapidly to 1.9 cP after 2 hours of hydrolysis, after which the viscosity gradually decreased. After 11 hours of hydrolysis, the decomposition was so complete that no viscosity was measured. Therefore, hydrolysis for 2 hours or more is effectively judged to remove the viscosity of the cheonnyeoncho extract.
총당 및 산성당 함량 Total sugar and acid sugar content
가수분해 시간에 따른 천년초 Rapidase/Viscozyme 가수분해물의 총당과 산성당의 함량을 측정한 결과, 가수분해 시간이 증가할수록 총당과 산성당이 증가하는 경향이 나타났다(도 12). 가수분해 전 총당의 함량은 5. 05 mg/mL였으나, 2시간 가수분해 후 9.75 mg/mL로 증가하였으며, 그 후 약간 증가하였다가 감소하는 등 기복을 거쳐, 8시간 이후부터는 총당 함량이 소폭이지만 꾸준히 증가하였다. 산성당인 Uronic acid는 가수분해 2시간 후 1088.34 mg/mL에서 2685.51 mg/mL로 급격히 증가하였으며, 그 후 가수분해 12시간 후까지는 시간당 증가폭이 처음 2시간처럼 크지는 않으나 Uronic acid 함량이 상당 수준까지 증가하였다. 그러나 가수분해 후 12시간이 경과한 이후로는 Uronic acid 함량 증가가 시간 대비 미비한 수준이었다. 그러므로 천년초 가수분해물을 유효성분으로 포함하는 면역 개선용 건강기능식품을 제조하려는 경우, 가수분해 시간을 12시간으로 하는 것이 바람직할 것이다.
As a result of measuring the content of total sugar and acidic sugar of millennial Rapidase / Viscozyme hydrolyzate according to hydrolysis time, total sugar and acidic sugar tended to increase with increasing hydrolysis time (FIG. 12). The total sugar content before hydrolysis was 5.05 mg / mL, but after 2 hours hydrolysis, it increased to 9.75 mg / mL, and then slightly increased and then decreased. After 8 hours, the total sugar content was slightly decreased. Steadily increased. Uronic acid, an acidic sugar, increased rapidly from 1088.34 mg / mL to 2685.51 mg / mL after 2 hours of hydrolysis, after which the hourly increase was not as large as the first 2 hours, but the uronic acid content increased to a significant level. It was. However, after 12 hours of hydrolysis, the increase in uronic acid content was insignificant over time. Therefore, if you want to prepare a health functional food for immune improvement containing the cheonnyeoncho hydrolyzate as an active ingredient, it would be preferable to set the hydrolysis time to 12 hours.
폴리페놀Polyphenols
2시간 동안 천년초를 Rapidase/Viscozyme 혼합 효소액으로 가수분해한 경우, 폴리페놀 함량이 672.9 mg/mL에서 820.13 mg/mL으로 증가하였다. 그 후 가수분해 8시간까지는 비록 증가폭이 처음 2시간만큼 크지는 않았으나 유의한 수준으로 증가하였다(8시간 가수분해 시 폴리페놀 함량 856.48 mg/mL). 그러나 11시간 및 24시간 가수분해 시 각각 852.20과 863.90 mg/mL의 함량을 보였으며, 이후 24시간 가수분해한 경우까지 주기적으로 측정한 결과 함량 변화는 미비한 것으로 확인되었다. 그러므로 천년초 가수분해물을 항산화 용도로 이용할 경우, 8시간 이상 가수분해할 필요는 없을 것으로 보인다.
When hydrolyzed cheonnyeoncho with Rapidase / Viscozyme mixed enzyme solution for 2 hours, the polyphenol content increased from 672.9 mg / mL to 820.13 mg / mL. Thereafter, up to 8 hours of hydrolysis, although the increase was not as great as the first 2 hours, it increased to a significant level (polyphenol content of 856.48 mg / mL at 8 hours of hydrolysis). However, the contents of 852.20 and 863.90 mg / mL were observed at 11 and 24 hours of hydrolysis, respectively, and the change in content was found to be insignificant as a result of periodic measurement until 24 hours of hydrolysis. Therefore, if the millennial hydrolyzate is used for antioxidant use, it is not necessary to hydrolyze more than 8 hours.
이상의 결과를 종합하여 고려할 때, 천년초 가수분해물의 용도에 따라 가수분해 시간을 조절하는 것이 바람직하다. 예컨대, 천년초 가수분해물을 유효성분으로 포함하는 면역 개선용 건강기능식품을 제조하려는 경우, 가수분해 시간을 12시간으로 하는 것이 유리하나, 천년초 가수분해물을 포함하는 항산화식품을 제조하는 경우, 8시간 동안만 가수분해하여도 목적한 효과를 달성할 수 있을 것이다.
In consideration of the above results, it is preferable to adjust the hydrolysis time according to the use of the millennial hydrolyzate. For example, when preparing a health functional food for improving immunity comprising a cheonnyeoncho hydrolyzate as an active ingredient, it is advantageous to have a hydrolysis time of 12 hours, but when preparing an antioxidant food containing a cheonnyeoncho hydrolyzate, for 8 hours Only hydrolysis will achieve the desired effect.
<실시예 6> 천년초 라피데이즈/비스코자임 가수분해 공정에 따른 천년초 농축물의 항산화 활성 및 면역기능 증진 활성Example 6 Antioxidant Activity and Immune Function Enhancement Activity of Millennial Concentrates by Millennial Rapids / Biscozyme Hydrolysis Process
<실험예 1> 천년초 라피데이즈/비스코자임 가수분해물 및 천년초 열수 추출/농축액의 제조
Experimental Example 1 Preparation of Millennial Rapids / Biscocozyme Hydrolyzate and Millennial Hydrothermal Extraction / Concentrate
공정 AProcess A
천년초 1.0 kg을 수세하고 가시를 제거한 후, 여기에 물을 2.5 kg 가하고 마쇄하여 천년초액을 제조하였다. 상기 천년초액에 라피데이즈/비스코자임을 1:3으로 혼합한 효소 혼합액을 50 mL/kg 가하여 40℃에서 12 시간 동안 가수분해하였다. 그리고 95℃로 15분간 열처리하여 효소 활성 제거 및 살균 공정을 수행하였다. 효소활성이 제거된 천년초 가수분해액을 여과한 후 농축하여 농축액을 제조하였다.
After milling 1.0 kg of cheonnyeoncho water and removing thorns, 2.5 kg of water was added thereto, followed by grinding, to prepare a millennial vinegar. 50 mL / kg of an enzyme mixture mixed with Rapidase / Biscocozyme 1: 3 was added to the millennial solution and hydrolyzed at 40 ° C. for 12 hours. And heat treatment at 95 ℃ for 15 minutes to remove the enzyme activity and sterilization process. The cheonnyeoncho hydrolysis solution from which the enzyme activity was removed was concentrated by filtration.
공정 BProcess B
천년초 1.0 kg을 수세하고 가시를 제거한 후 마쇄하고 이를 95 ℃에서 4 시간 동안Wash 1.0 kg of cheonnyeoncho, remove the thorns and crush them
주정 추출하였다. 그 후 천년초 추출액을 여과 및 농축하고, 라피데이즈/비스코자임을 1:3으로 혼합한 효소 혼합액을 50 mL/kg 가하여 40℃에서 6시간 동안 가수분해하였다. 그리고 95℃로 15분간 열처리하여 효소 활성 제거 및 살균 공정을 수행하였다. 효소활성이 제거된 천년초 추출액을 여과한 후 농축하여 농축액을 제조하였다.
Alcohol was extracted. After that, the millennial extract was filtered and concentrated, and 50 mL / kg of an enzyme mixture mixed with Rapidase / Biscocozyme 1: 3 was added and hydrolyzed at 40 ° C. for 6 hours. And heat treatment at 95 ℃ for 15 minutes to remove the enzyme activity and sterilization process. The cheonnyeoncho extract from which the enzyme activity was removed was filtered and concentrated to prepare a concentrate.
대조군Control
대조군으로는 천년초 열수 추출/농축액을 제조하였다. 즉, 천년초 1.0 kg을 수세하고 가시를 제거한 후, 여기에 물을 2.5 kg 가하고 마쇄하여 천년초액을 제조하였다. 그 후 상기 천년초액을 95℃로 6시간동안 가열하여 열수추출한 후 여과 및 농축하였다.
A millennial hot water extract / concentrate was prepared as a control. That is, 1.0 kg of cheonnyeoncho was washed with water and thorns were removed, and 2.5 kg of water was added thereto, followed by crushing to prepare a millennial vinegar. Thereafter, the millennial liquor was heated to 95 ° C. for 6 hours, followed by hot water extraction, followed by filtration and concentration.
<실험예 2> 천년초 라피데이즈/비스코자임 가수분해 농축물의 생리활성Experimental Example 2 Physiological Activity of Rapids / Biscocozyme Hydrolysates
상기 실험예 1에서 제조한 천년초 농축액들의 생리 활성을 측정한 결과, 천년초 라피데이즈/비스코자임 가수분해 농축물은 공정 A에 의하여 제조된 농축물 및 공정 B에 의하여 제조된 농축물 모두 대조군인 천년초 열수 추출/농축물에 비하여 총당, 산성당, 폴리페놀 함량이 모두 높았다(도 14 및 표 4). 또한 농축액의 효율 역시 열수 추출물에 비하여 라피데이즈/비스코자임 가수분해 농축물이 높았다.
As a result of measuring the physiological activity of the cheonnyeoncho concentrate prepared in Experimental Example 1, the cheonnyeoncho rapidase / biscozyme hydrolyzate concentrate is a control of both the concentrate prepared by step A and the concentrate prepared by step B cheonnyeoncho hot water Compared with the extract / concentrate, the total sugar, acid sugar, and polyphenol content were all higher (FIG. 14 and Table 4). In addition, the efficiency of the concentrate was higher in the rapids / biscozyme hydrolyzate than the hydrothermal extract.
<실험예 3> 천년초 라피데이즈/비스코자임 가수분해 농축물의 항산화 활성<
천년초 1.0 kg을 수세하고 가시를 제거한 후, 여기에 물을 1.0 내지 5 kg 가하고 마쇄하였다. 상기 물과 천년초의 비율이 상이한 천년초액들을 이용하여 공정 A 및 공정 B에 의하여 제조한 천년초 라피데이즈/비스코자임 가수분해 농축물 및 천년초 열수 추출/농축액의 항산화 활성을 측정하였다. 항산화 활성은 ABTS와 DPPH 라디칼 소거능에 의하여 측정하였다.
1.0 kg of cheonnyeoncho was washed with water and thorns were removed, and then 1.0 to 5 kg of water was added thereto, followed by grinding. The antioxidant activity of the millennial rapidase / biscozyme hydrolyzate and millennial hydrothermal extract / concentrate prepared by Process A and Process B were measured using the millennial liquors having different ratios of water and millennial. Antioxidant activity was measured by ABTS and DPPH radical scavenging ability.
ABTS 라디칼 소거능은 ABTS cation decolorization assay법에 의해 시행하였으며(Re R, Pellegrini N, Proteggente A, Pannala A, Yang M, Rice-Evans C. 1999. Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic Biol Med 26: 1231-1237.), ABTS 7.4 mM과 potassium persulphate 2.6 mM을 하루 동안 암소에 방치하여 ABTS 라디칼을 형성시킨 후, 이 용액을 734 nm에서 흡광도 값이 1.0 이 되도록 몰 흡광계수(ε=3.6×104 M-1cm-1)를 이용하여 증류수로 희석하였다. 희석된 ABTS 라디칼 용액 1 mL에 추출액 50 μL를 가하여 흡광도의 변화를 정확히 90분 후에 측정하였다.
ABTS radical scavenging activity was performed by the ABTS cation decolorization assay method (Re R, Pellegrini N, Proteggente A, Pannala A, Yang M, Rice-Evans C. 1999. Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic Biol Med 26: 1231-1237.), ABTS 7.4 mM and 2.6 mM potassium persulphate were left in the dark for 1 day to form ABTS radicals, and then the solution was molar extinction coefficient (ε = 3.6 ×) at 734 nm to obtain an absorbance value of 1.0. 104 M-1 cm-1) was diluted with distilled water. 50 μL of the extract was added to 1 mL of diluted ABTS radical solution, and the change in absorbance was measured after exactly 90 minutes.
DPPH 라디칼 소거능에 의한 항산화활성은 Kim 등(Kim DO, Lee KW, Lee HJ, Lee CY. 2002. Vitamin C equivalent antioxidant capacity (VCEAC) of phenolic phytochemicals. J Agric Food Chem 50: 3713-3717.)의 방법을 변형하여 실행하였다. 0.2 mM DPPH 용액 1 mL에 추출액 50 μL를 가하여 흡광도의 변화를 520 nm에서 정확히 30분 후에 측정하였다. Antioxidant activity by the DPPH radical scavenging activity is Kim et al. (Kim DO, Lee KW, Lee HJ, Lee CY. 2002. Vitamin C equivalent antioxidant capacity (VCEAC) of phenolic phytochemicals. J Agric Food Chem 50: 3713-3717.) Was modified. 50 μL of the extract was added to 1 mL of 0.2 mM DPPH solution and the change in absorbance was measured after exactly 30 minutes at 520 nm.
ABTS 라디칼 소거능 및 DPPH 라디칼 소거능은 아래의 식으로 계산되었다.
ABTS radical scavenging activity and DPPH radical scavenging ability were calculated by the following equation.
<식 1><
ABTS 라디칼 소거능(%)=(Ab-As)/Ab×100
ABTS radical scavenging ability (%) = (Ab-As) / Ab × 100
Ab: 농축물 대신 증류수를 넣었을 때의 흡광도 값의 변화Ab: change in absorbance value when distilled water is added instead of concentrate
As: 농축물을 넣었을 때의 흡광도 값
As: absorbance value when concentrate is added
<식 2><
DPPH 라디칼 소거능(%)=(Ab-As)/Ab×100
DPPH radical scavenging activity (%) = (Ab-As) / Ab × 100
Ab: 농축물 대신 증류수를 넣었을 때의 흡광도 값의 변화Ab: change in absorbance value when distilled water is added instead of concentrate
As: 농축물을 넣었을 때의 흡광도 값
As: absorbance value when concentrate is added
항산화 활성 측정 결과, 공정 A에 의하여 제조된 천년초 라피데이즈/비스코자임 가수분해 농축물은 농축물의 농도 범위 전반에 걸쳐 천년초 열수 추출 농축물보다 DPPH 라디칼 소거능이 높았으며, 공정 B에 의하여 제조된 천년초 라피데이즈/비스코자임 가수분해 농축물은 저농도에서는 열수 추출/농축물보다 DPPH 라디칼 소거능이 높았으나 고농도에서는 열수 추출/농축물보다 낮았다. 그러나 천년초 라피데이즈/비스코자임 가수분해 농축물 모두와 대조군 사이에 있어 DPPH 라디칼 소거능에 큰 차이가 있는 것은 아니었다(도 15). 반면 ABTS 라디칼 소거능의 경우, 농축물의 농도 범위 전반에 걸쳐 천년초 라피데이즈/비스코자임 가수분해 농축물이 천년초 열수 추출 농축물보다 상당히 컸으며, 그 차이는 농축물의 농도가 증가할수록 커지는 경향을 보였다(도 16). 특히 공정 A에 의하여 제조된 천년초 라피데이즈/비스코자임 가수분해 농축물은 대조군은 물론 공정 B에 의하여 제조된 것보다 ABTS 라디칼 소거능이 상당히 높았다.
As a result of the antioxidant activity measurement, the millennial rapidase / biscozyme hydrolyzate concentrate prepared by Process A had a higher DPPH radical scavenging activity than the millennial hydrothermal extract concentrate over the concentration range of the concentrate, and the millennial raffy prepared by Process B. Days / biscozyme hydrolyzate concentrates showed higher DPPH radical scavenging ability than hydrothermal extract / concentrate at low concentrations, but lower than hydrothermal extract / concentrate at high concentrations. However, there was not a significant difference in DPPH radical scavenging ability between both millipria rapheides / biscozyme hydrolyzate concentrates and controls (FIG. 15). On the other hand, for ABTS radical scavenging activity, the millennial rapidase / biscozyme hydrolyzate concentrate was significantly larger than the millennial hydrothermal extract concentrate over the concentration range of the concentrate, and the difference tended to increase with increasing concentration of the concentrate (FIG. 16). In particular, the millennial rapidase / biscozyme hydrolyzate concentrate prepared by Process A had significantly higher ABTS radical scavenging capacity than that prepared by Process B as well as the control.
<실험예 3> 천년초 라피데이즈/비스코자임 가수분해 농축물의 면역기능 증진 활성Experimental Example 3 Immune Function Enhancing Activity of Rapidis / Biscocozyme Hydrolysates
실험예 1에서 제조한 천년초 라피데이즈/비스코자임 가수분해 농축물들 및 천년초 열수 추출/농축물에 있어서, 항보체 활성의 원인 물질인 활성다당 함량을 측정하였다. 그 결과, 천년초 열수 추출/농축물은 5.85 mg/mL의 활성다당을 함유하고 있었으며, 공정 A 및 공정 B에 의하여 제조된 천년초 라피데이즈/비스코자임 가수분해 농축물은 각각 9.07 mg/mL 및 6.25 mg/mL의 활성 다당을 함유하고 있었다. 그러므로 천년초를 라피데이즈/비스코자임 1:3 혼합 효소액으로 가수분해시, 천년초의 활성다당 추출량이 높으며, 특히 공정 A로 천년초 가수분해 농축물을 제조시, 활성 다당 추출량이 높았다.
In the millennial rapidase / biscozyme hydrolyzate concentrates prepared in Experimental Example 1 and the millennial hydrothermal extract / concentrate, the active polysaccharide content as a causative agent of anti-complement activity was measured. As a result, the millennial hydrothermal extract / concentrate contained 5.85 mg / mL of active polysaccharide, and the millennial rapidase / biscozyme hydrolyzate concentrates prepared by Process A and Process B were 9.07 mg / mL and 6.25 mg, respectively. It contained / mL of active polysaccharide. Therefore, when hydrolyzing Chun-na-cho with Rapidase / Biscocozyme 1: 3 mixed enzyme solution, the amount of active polysaccharide extracted from Cheon-nyeon was high.
본 발명의 천년초 추출물의 제조 방법은 천년초의 점성을 제거하는데 효과적일 뿐 아니라, 추출물 내 활성 물질 또한 종래 천년초 추출방법에 의한 천년초 추출물보다 높게 함유되어 있다. 그러므로 본 발명의 천년초 추출물의 제조방법 및 이를 이용한 천년초 추출물은 천년초의 가공 및 이용을 보다 용이하게 할 것으로 기대된다.
The preparation method of the cheonnyeoncho extract of the present invention is not only effective in removing the viscosity of cheonnyeoncho, but also contains the active substance in the extract higher than the cheonnyeoncho extract by the conventional method. Therefore, the preparation method and the cheonnyeoncho extract using the cheonnyeoncho extract of the present invention is expected to facilitate the processing and use of cheonnyeoncho.
Claims (9)
Method of producing a cheonnyeoncho extract comprising the step of hydrolyzing by adding rapidase or biscozyme to Pounitia humifusa to remove the viscosity of cheonnyeoncho.
Method of producing a cheonnyeoncho extract comprising the step of hydrolysis by adding a mixture of rapidase and biscozyme to Pounitia humifusa to remove the viscosity of cheonnyeoncho.
상기 혼합물은 라피데이즈 및 비스코자임이 2:2 내지 1:3의 비율로 혼합된 것을 특징으로 하는 천년초 추출물의 제조 방법.
The method of claim 2,
The mixture is a method for producing a cheonnyeoncho extract, characterized in that the rapids and biscozyme is mixed in a ratio of 2: 2 to 1: 3.
2시간 내지 12시간동안 가수분해시키는 것을 특징으로 하는 제조 방법.
The method of claim 1,
Process for hydrolysis for 2 to 12 hours.
2) 수세 및 가시 제거된 천년초에 물을 첨가하여 마쇄하는 단계;
3) 마쇄된 천년초에 라피데이즈(rapidase) 또는 비스코자임(viscozyme)을 처리하고 가수분해하는 단계;
4) 열처리하여 효소 활성을 제거하는 단계;
5) 단계 4)에서 수득한 천년초 추출액을 여과 또는 원심분리하는 단계;및
6) 단계 5)에서 수득한 여과 또는 원심분리된 천년초 추출액을 농축하는 단계를 포함하는 천년초 추출물의 제조 방법.
1) washing and thorn removal of Pounitia humifusa;
2) crushing by adding water to the washed and thorn-free cheonnyeoncho;
3) treating and hydrolyzing rapidase or biscozyme in the milled millennial;
4) heat treatment to remove enzyme activity;
5) filtering or centrifuging the cheonnyeoncho extract obtained in step 4); and
6) A method for producing a cheonnyeoncho extract comprising the step of concentrating the filtered or centrifuged cheonnyeoncho extract obtained in step 5).
A cheonnyeoncho extract prepared by the method of any one of claims 1 to 5.
Cosmetic composition comprising the cheonnyeoncho extract of claim 6.
Food composition comprising the cheonnyeoncho extract of claim 6.
상기 식품 조성물은 항산화 식품 조성물 또는 면역증진용 건강보조식품 조성물인 것을 특징으로 하는 식품 조성물.
The method of claim 8,
The food composition is a food composition, characterized in that the antioxidant food composition or health supplement food composition for immune promotion.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020100007416A KR100975278B1 (en) | 2010-01-27 | 2010-01-27 | Extraction method of opuntia humifusa using enzyme hydrolysis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020100007416A KR100975278B1 (en) | 2010-01-27 | 2010-01-27 | Extraction method of opuntia humifusa using enzyme hydrolysis |
Publications (1)
Publication Number | Publication Date |
---|---|
KR100975278B1 true KR100975278B1 (en) | 2010-08-11 |
Family
ID=42759504
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020100007416A KR100975278B1 (en) | 2010-01-27 | 2010-01-27 | Extraction method of opuntia humifusa using enzyme hydrolysis |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100975278B1 (en) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101181802B1 (en) * | 2011-11-29 | 2012-09-11 | 월드웨이(주) | Anti-oxidant and anti-cholesterol composition containing opuntia humifusa extract |
KR101257797B1 (en) | 2012-06-01 | 2013-04-29 | 한림대학교 산학협력단 | Composition for regulation of blood glucose containing enzyme modified extract of nopal |
KR101411998B1 (en) * | 2012-01-06 | 2014-07-18 | (주)네오크레마 | Preparation of opuntia humifusa extract using enzymes under ultra high pressure |
KR20160092345A (en) * | 2015-01-27 | 2016-08-04 | 대구한의대학교산학협력단 | Souce composition comprising red crab steaming liquid and method thereof |
KR101731480B1 (en) | 2015-01-27 | 2017-05-08 | 김수야 | A cosmetic composition comprising eastern prickly pear extract having antioxidant activity |
KR101877875B1 (en) * | 2017-02-28 | 2018-07-12 | 농업회사법인 주식회사 장성조미채소 | Method for producing Allium hookeri soy sauce and Allium hookeri soy sauce using thereof |
KR101888555B1 (en) * | 2014-09-26 | 2018-08-16 | 신대용 | Composition comprising dried mixture of red shale and herbal medicine for immune enhancement |
KR20190067610A (en) * | 2017-12-07 | 2019-06-17 | 주식회사 아리바이오 | Cosmetic compositions comprising millennium ginseng and process for their preparation |
WO2021112266A1 (en) * | 2019-12-02 | 2021-06-10 | 주식회사 건풍바이오 | Animal feed additive for reducing oxidative stress and improving feed efficiency, and production method therefor |
KR102567019B1 (en) * | 2023-04-14 | 2023-08-17 | 주식회사 캑터바이오 | Method for preparing extracts of Eastern prickly pear stem |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR970032503A (en) * | 1995-12-22 | 1997-07-22 | 신철주 | Method for producing juice from leaves and berries of cactus and functional food containing cactus juice |
KR20060029385A (en) * | 2004-10-01 | 2006-04-06 | 주식회사롯데햄.롯데우유 | Opuntia ficus-indica extracting method and dairy beverage containing cactus extract |
KR20060111989A (en) * | 2005-04-26 | 2006-10-31 | 박준 | Composite made of opuntia ficus to set soybean oil for bean-curd and method for producing the same |
KR20080103748A (en) * | 2007-05-25 | 2008-11-28 | 강영분 | Making method of drink |
-
2010
- 2010-01-27 KR KR1020100007416A patent/KR100975278B1/en active IP Right Grant
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR970032503A (en) * | 1995-12-22 | 1997-07-22 | 신철주 | Method for producing juice from leaves and berries of cactus and functional food containing cactus juice |
KR20060029385A (en) * | 2004-10-01 | 2006-04-06 | 주식회사롯데햄.롯데우유 | Opuntia ficus-indica extracting method and dairy beverage containing cactus extract |
KR20060111989A (en) * | 2005-04-26 | 2006-10-31 | 박준 | Composite made of opuntia ficus to set soybean oil for bean-curd and method for producing the same |
KR20080103748A (en) * | 2007-05-25 | 2008-11-28 | 강영분 | Making method of drink |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101181802B1 (en) * | 2011-11-29 | 2012-09-11 | 월드웨이(주) | Anti-oxidant and anti-cholesterol composition containing opuntia humifusa extract |
KR101411998B1 (en) * | 2012-01-06 | 2014-07-18 | (주)네오크레마 | Preparation of opuntia humifusa extract using enzymes under ultra high pressure |
KR101257797B1 (en) | 2012-06-01 | 2013-04-29 | 한림대학교 산학협력단 | Composition for regulation of blood glucose containing enzyme modified extract of nopal |
KR101888555B1 (en) * | 2014-09-26 | 2018-08-16 | 신대용 | Composition comprising dried mixture of red shale and herbal medicine for immune enhancement |
KR20160092345A (en) * | 2015-01-27 | 2016-08-04 | 대구한의대학교산학협력단 | Souce composition comprising red crab steaming liquid and method thereof |
KR101703411B1 (en) * | 2015-01-27 | 2017-02-06 | 대구한의대학교산학협력단 | Souce composition comprising red crab steaming liquid and method thereof |
KR101731480B1 (en) | 2015-01-27 | 2017-05-08 | 김수야 | A cosmetic composition comprising eastern prickly pear extract having antioxidant activity |
KR101877875B1 (en) * | 2017-02-28 | 2018-07-12 | 농업회사법인 주식회사 장성조미채소 | Method for producing Allium hookeri soy sauce and Allium hookeri soy sauce using thereof |
KR20190067610A (en) * | 2017-12-07 | 2019-06-17 | 주식회사 아리바이오 | Cosmetic compositions comprising millennium ginseng and process for their preparation |
KR102233574B1 (en) * | 2017-12-07 | 2021-03-31 | 주식회사 아리바이오 | Cosmetic compositions comprising millennium ginseng and process for their preparation |
WO2021112266A1 (en) * | 2019-12-02 | 2021-06-10 | 주식회사 건풍바이오 | Animal feed additive for reducing oxidative stress and improving feed efficiency, and production method therefor |
KR102567019B1 (en) * | 2023-04-14 | 2023-08-17 | 주식회사 캑터바이오 | Method for preparing extracts of Eastern prickly pear stem |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100975278B1 (en) | Extraction method of opuntia humifusa using enzyme hydrolysis | |
KR102032033B1 (en) | Fermentation method of lactic acid bacteria using citrus fruit and its use | |
KR102118697B1 (en) | Manufacturing method of sprout barley juice powder and sprout barley juice powder mixing compound therof | |
KR101704974B1 (en) | A production method of sugaless traditional sikhye more than 13 brix | |
JP2009057481A (en) | Antioxidant composition | |
CN109662222A (en) | Plant beverage and preparation method thereof with cell repair and promotion cell viability | |
KR102137136B1 (en) | Composition comprising pumpkin hydrolysis extract, amorphophallus paeoniifolius hydrolysis extract, curcuma extract and cacao nibs extract | |
KR101411998B1 (en) | Preparation of opuntia humifusa extract using enzymes under ultra high pressure | |
CN101972019B (en) | Facial beautification and health care function beverage made of radix polygonati officinalis and production method thereof | |
Selvaraj et al. | Virgin coconut oil: A nutraceutical and therapeutic food | |
KR20140046865A (en) | Fermentational composition comprising portulaca oleracea l. and rice bran and the method of manufacturing thereof | |
KR20080029035A (en) | Natural cosmetic composition having the cactus fermented liquid and grape seed extracts | |
KR20160060834A (en) | Compositions for culture media of Kefir grain comprising plant extract and compositions for improving skin conditions comprising fermented products using the same | |
US20100008877A1 (en) | Composition for improving skin condition | |
JP7170357B2 (en) | External agent for hair growth | |
JP2007269659A (en) | Antioxidant composition | |
KR20190014864A (en) | Blueberry raw jam and the preparing process thereof | |
KR101586053B1 (en) | method manufacturing Powder of Cudrania tricuspidata | |
KR20220099176A (en) | A composition with anti-inflammation activity and skin elasticity improvement efficacy comprising mixed ferment extracts of natural products | |
KR20180024481A (en) | Method for preparing apricot extract, the apricot extract prepared therefrom, and skin care or cosmetic composition comprising the apricot extract | |
KR101204354B1 (en) | A preparation method for pepino concentrated composition having improved filtration rate and a concentrated composition prepared thereby | |
JP3779740B2 (en) | Agents for preventing and treating obesity from rice | |
KR102169081B1 (en) | Composition for stimulating hair growth and preventing depilation containing oregano oil as an active ingredient | |
KR102508753B1 (en) | Method of Preparing Concentrate of Deer Antlers | |
KR101356710B1 (en) | Manufacturing method for red pepper paste using red ginseng powder and gastrodia elata blume powder |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
A302 | Request for accelerated examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130730 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20140617 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20150528 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20160524 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20170724 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20190603 Year of fee payment: 10 |